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Resumo 
A revolução dos dispositivos móveis está a originar um aumento de dispositivos de saúde 
vestíveis, levando a um crescimento na área da monitorização ambulatória. Estes dispositivos 
podem ser utilizados no tratamento ambulatório de doenças e seu diagnóstico, área onde já 
possuem uma posição de relevo, na monitorização pessoal e na melhoria do desempenho 
desportivo, fornecendo informações fisiológicas e ambientais ao longo das diferentes situações 
diárias. Actualmente, existem vários dispositivos de saúde vestíveis no mercado, sendo um deles 
produto da Biodevices, S.A., denominado de Vital Jacket®. Este é capaz de monitorizar, 
continuamente, o sinal de electrocardiograma, ritmo cardíaco e dados de acelerómetro, 
utilizando uma smart t-shirt, isto é, uma t-shirt com electrónica incorporada no tecido. 
Esta Tese de Mestrado tem como objetivo propor, desenhar e implementar o primeiro 
protótipo de um novo dispositivo de saúde vestível, denominado VitalLogger. Este dispositivo 
estende a tecnologia da Biodevices. S.A., viabilizando uma possível expansão do Vital Jacket® 
para outros mercados. 
VitalLogger é um novo dispositivo capaz de adquirir vários sinais fisiológicos e ambientais, de 
acordo com as preferências do utilizador, que estende o número de variáveis adquiridas pela 
tecnologia da Biodevices. S.A.. Antes do desenvolvimento desta extensão, foi necessário realizar 
uma pesquisa aprofundada sobre dispositivos de saúde vestíveis e quais os sensores/cenários 
com maior necessidade de monitorização ambulatória, de forma a realizar uma extensão com 
viabilidade económica e procura no mercado. Esta pesquisa abordou as seguintes áreas: 
arquiteturas dos dispositivos de saúde vestíveis e quais os sensores onde se está a fazer um 
maior esforço de implementação na monitorização ambulatória; sinais fisiológicos e ambientais 
mais necessitados, tanto na área médica como na monitorização pessoal; quais as tendências de 
mercado para os próximos anos, para perceber se os avanços tecnológicos e as necessidades são, 
economicamente, interessantes e viáveis para investir num futuro próximo. Após reunir esta 
informação, a Biodevices. S.A. decidiu estender a sua tecnologia de forma a adquirir valores de 
saturação de oxigénio, temperatura ambiental, humidade relativa ambiental e dados de 
giroscópio, não sendo este último implementado, por falta de tempo. 
O desenvolvimento do VitalLogger consistiu na criação e implementação de uma placa 
eletrónica que estende a tecnologia da Biodevices. S.A, sendo este processo dividido em três 
fases: desenho, produção e montagem da placa electrónica, recorrendo a um software de 
desenho de circuitos impressos; desenvolvimento em C do firmware necessário para incorporar 
os sensores implementados no microcontrolador, utilizando o software de IDE da Microchip;  
por fim, calibração e validação dos sensores, utilizando dispositivos comerciais.  
No final, o primeiro protótipo do VitalLogger foi contruído com sucesso, obtendo-se um novo 
dispositivo de saúde vestível, capaz de adquirir, continuamente, valores de electrocardiograma, 
ritmo cardíaco, acelerómetro, saturação de oxigénio e temperatura e humidade relativa 
ambiente. 
O VitalLogger está totalmente adaptado à tecnologia da Biodevices. S.A. e é desenvolvido a 
pensar nas tendências de mercado e necessidades dos próximos anos, capaz de contribuir para 
uma possível expansão desta empresa para outras áreas de monitorização ambulatória. 
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Abstract 
Current mobile revolution is leading to an increase of wearable health device development 
and consequently a growth in ambulatory monitoring area. These systems can be applied in 
ambulatory diseases management and it’s diagnose, a very relevant use, in personal health 
monitoring or in sports performance enhancement, providing physiological and ambiance data 
during daily normal activities. Nowadays there are several devices in the market with this type 
of technology, being one of them the main product of Biodevices, S.A., named Vital Jacket®. It can 
continuously monitoring electrocardiogram, heart rate and accelerometer data using a smart t-
shirt, a t-shirt with textile embedded electronic. 
This Master Thesis objective is to propose, design and implement the first prototype of a new 
wearable health device denominated VitalLogger. This device extends Biodevices, S.A. 
technology allowing a possible market expansion of Vital Jacket®.  
VitalLogger is a new device capable of acquire physiological and ambiance variables 
according to the user preferences, extending the amount of signals acquired by Biodevices, S.A. 
technology. After the extension development, a deep research was made regarding wearable 
health devices and their sensors/scenarios with a higher ambulatory monitoring need, enabling 
to design an extension with economic viability and market desire. This research addressed the 
following areas: wearable health devices architecture and technological improvements, 
including in which sensors is being made a higher effort to implement them in ambulatory 
monitoring; the main required physiological signs to be monitored, both in medical and health 
areas; market trends for the next few years, understanding the economic viability of the 
technological advances and costumers needs. After gather all this information, it was presented 
to Biodevices, S.A., who decided to extend its technology to acquire oxygen saturation values, 
ambiance temperature, ambiance relative humidity and gyroscope data. This last one was not 
implemented due to lack of time. 
The development of VitalLogger consisted in the design and implementation of an electronic 
that extends Biodevices, S.A. technology. This process was divided in three main phases: design, 
production and assembling of the electronic board using printed circuit board design software; 
development in C of the firmware needed to incorporate the implemented sensors in the 
microcontroller with Microchip IDE software; for last, calibration and validation of the sensors 
using commercial devices.  
In the end, the first VitalLogger was successfully built, obtaining a new wearable health 
device capable to continuously acquire electrocardiogram, heart rate, accelerometer data, 
oxygen saturation values and ambiance temperature and relative humidity. 
VitalLogger is totally adapted to Biodevices S.A. technology and developed according to 
market trends and necessities for the following years, with the possibility to contribute in a 
potential expansion of this company in other ambulatory monitoring areas.   
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  Chapter 1
Introduction 
earable Health Devices are becoming one of the next generations gadgets, regarding 
medical and personal use. Besides their medical applications, these monitoring 
devices are increasing their reputation in personal monitoring, leading to a self-
monitoring between athletes and common people to get information about their physiologic 
status anytime and anywhere. Wearable health devices are expanding their application to be 
included in daily activities, so there is a need for improving their technology to get higher 
viability, portability and autonomy. 
This Master Thesis was developed in the Faculty of Engineering of the University of Porto and 
in INESC TEC Porto with the collaboration of Biodevices, S.A. The aim of this work directly 
related to wearable health devices, presenting the development of a wearable health device 
prototype that can be implemented as a possible future product. This work was included in the 
Biomedical Research And INnovation LABoratory (BRAIN-LAB), one of the I&D groups hosted in 
INESC TEC Porto, and supervised by Professor Ph.D. João Paulo Cunha. 
1.1.  Background and Context 
Wearable health devices are able to continuously monitoring physiological parameters for 
several purposes, from a simple fitness activity, evaluating human body response during 
physical efforts to a medical situation where patients’ monitoring, inside and outside clinical 
environments, is indispensable. The use of wearable health devices in fitness and wellness as 
also in healthcare and medical applications is increasing and a higher viability of these devices is 
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leading to a revolution in this area, which is expected to grow about 30% only this year 
comparing to the last one, according to IHS Inc. [1] 
Nowadays, people have a higher desire to monitoring their human body with new gadgets. 
Wearable health devices meets this recent trend, being able to monitor one or more vital signs 
using one or more small wearable devices, registering vital data and/or sending it in real-time 
using wireless protocols or mobile communications. These characteristics allow medical 
specialists to receive patient’s physiological data anywhere, improving healthcare conditions, 
lowering clinical costs and enabling the acquisition of vital parameters during daily activities. [2, 
3] There are already commercial devices with all these requirements and with multiple 
physiological signs acquisition, but normally only for personal use because most of them are not 
certified as medical devices to be used in clinical environment, providing viable medical 
information. Vital Jacket®, from Biodevices, S.A., is one of the few exceptions to the previous 
statement. It is the first worldwide certified smart t-shirt medical device, able to acquire and 
record ambulatory electrocardiogram (ECG) signal, with a Bluetooth connection to transmit 
real-time ECG data to a mobile device, if required. 
Although Vital Jacket® is on the top edge of technology, it is always good to think in possible 
new market expansions to this product. This Master Thesis is inserted in this theme, presenting 
a new device, named VitalLogger, containing an implementation for a possible expansion of Vital 
Jacket® device. This possible expansion can contribute to help medical specialist in disease 
prevention, prediction and management of disorders. This possible expansion will also result in 
a more reliable and useful device, when compared to a single physiological parameter 
monitoring device [2]. More monitored parameters can also increase the commercial desire 
outside clinical areas, providing a more complete monitoring of human body, during daily 
activities and wellness or sport activities. This is an important aspect which is considered to 
have a direct influence in personal health monitoring, leading to a healthier worldwide 
population [4].  
VitalLogger development is part of a bigger project that includes another student’s Master 
Thesis projects. This big project has the aim to aggregate and synchronize as many vital and 
ambiance data as possible according to the user desire as it is explained in the beginning of 
Chapter 3. Figure 1.1.1 shows a resume of this bigger project, where VitalX, an Android 
application developed in another student Master Thesis, has an aggregate module that is able to 
gather, synchronously, all the data from external devices and smartphone sensors. The 
communication between VitalLogger and smartphones was also developed by another student 
during his Master Thesis project. This Master Thesis focus on the implementation of new 
sensors in VitalLogger and in the development of the low level firmware needed. 
 
Figure 1.1.1- Component Architecture of the Project where VitalLogger is inserted.  
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1.2.  Motivation 
Wearable health devices are evolving fast nowadays, attracting all kind of persons to use 
them on the daily activities, including medical specialist to get continuous physiological data 
from their patients to perform a reliable diagnostic or disease monitoring. 
The application of new electronic technology to capture physiological signs is one of the 
Biomedical Engineering areas, joining the human physiology with the electronic development. 
The physiological knowledge allows understanding human signals origin and its meaning in the 
human health; the electronic skills are important to be able to design a device capable to acquire 
these signals, using nowadays technologies or developing new ones. The relation between these 
two areas is increasing and leading to new technological advances in human body monitoring. 
To endorse my knowledge about this emerging area, nothing better than make a Master 
Thesis related to it, mainly when the work is made with the contribution of one of the pioneering 
companies on this area, Biodevices, S.A.  
This Master Thesis objective to create a proposal of a possible extension implementation for a 
wearable health device, that is already a product, is one of a kind opportunity. In this experience 
it was possible to apply knowledge acquired during this Master Degree and learned how to 
transform it in a commercial product with a promising place in the market. 
1.3.  Objectives 
This Master Thesis covers different areas related to wearable health devices, regarding their 
technology, how do they work, market trends and health and medical approaches. The 
development phase of this work is based on the creation of a prototype to extend an existing 
wearable health device, creating, for the first time, the VitalLogger device.  
This work main objective is to propose a possible market expansion to Biodevices, S.A. with a 
VitalLogger prototype containing more sensors, being capable to acquire more physiological 
data from the user. To perform such proposal, this work presents what is close to a complete 
process to decide and implement a new wearable health device prototype. After the prototype 
development itself, a research was made based on health and medical ambulatory necessities 
and their market viability, choosing and understanding what will be the best technological bet in 
this area.  To perform all this process this work is divided in four main objectives. 
 First one is to better understand how wearable health devices works, their generic 
architecture and the most recent technological advances worldwide in this area to comprehend 
in which branches of these devices is being made a higher effort in technological advances. 
The second objective is to research and analyze which are the most wanted and needed 
physiological parameters to be measured in an ambulatory monitoring, regarding a medical 
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approach and also a health approach, including self-monitoring, an area with a high growing 
nowadays. 
The third objective is related to the market and its future trends. An analysis of this area has a 
major importance when a product is proposed to a company, supporting its market viability and 
future sales profit. An overall market research was performed and then each wearable health 
device segment was deeper analyzed to obtain a feasible information about the future of this 
emerging area. 
Last, but not least objective is the prototype development. To get a decision from Biodevices, 
S.A., it was presented a proposal with the most promising monitoring scenarios and respective 
set of sensors based on the research made. Joined to this proposal, a market and trends analysis 
such as associated costs estimation were also presented to better support the company decision. 
The company verdict and forth objective of this Master Thesis is to develop a possible 
implementation of a prototype capable to extend their technology to acquire four new variables 
including oxygen saturation level, ambiance temperature and relative humidity and gyroscope 
data, taking the first step in the VitalLogger prototype. 
1.4.  Contributions 
This Master Thesis had two main contributions, one that is related to personal skills 
improvement, and other related to Biodevices, S.A. and their possible future expansion. 
Regarding the personal experience, this work was challenging, mainly in the prototype 
development phase where firmware and production hardware were made for the first time. The 
direct connection with Biodevices, S.A. personnel is one of the main enrichments of this work, 
leading to a faster learning process and easier adaptation to their technology. In the end, with 
the acquired skills during this Master Thesis concerning all the process from wearable health 
devices research passing for market analysis and ending in a product conception is going to be 
part of my personal education. This is one of the main contributions of this work because it will 
allow expanding my knowledge by learning new engineering areas that were not covered during 
this Master graduation and are directly related to future personal career interests. 
The collaboration of Biodevices, S.A. in this Master Thesis was an added value, enabling to 
contribute in a possible market expansion of this company regarding the implementation of new 
sensors. The final proposed prototype is totally adaptable to the most recent technology of 
Biodevices S.A. being totally able to be incorporated in their device and, who knows, be part of a 
possible future product. Moreover, this new prototype as the aim to contribute for the growing 
of wearable health devices worldwide, proposing a new device with real-life application that can 
contribute for a better health monitoring and human well-being. 
The collaboration of Biodevices, S.A. would never be possible without the non-disclosure 
agreement with INEST TEC. This Master Thesis was developed under this association, 
contributing to a higher proximity of these two identities, which directly led to a higher share of 
knowledge, technology and resources. 
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1.5.  Work Structure 
This Master Thesis is divided in 4 chapters. After first Chapter of introduction, three more 
chapters are presented: the second one is related to the wearable health devices research made; 
the third Chapter with the prototype development process; and the fourth Chapter makes some 
final remarks and conclusions, as also a discussion about what can be made as future work. 
Chapter 2 presents wearable health devices according to the literature in this area. The 
components architecture of these devices consists in the interconnection between several 
modules, so, an analysis of each one is made, discussing possible functionalities variations. Then, 
Biodevices, S.A. is presented, including their own wearable health device named Vital Jacket®. 
After this, some similar commercial devices and recent prototypes are shown to a make 
technological and market comparison. The following topic is focused on physiological signs in 
ambulatory monitoring, regarding two main aspects: medical specialists need to get the most 
complete monitoring from their patients to obtain reliable physiological information in 
ambulatory cases; nowadays society needs in their life care improvement and self-monitoring 
activities. The devices used to acquire each physiological sign are covered, regarding their 
technologies, implementations and also some recent prototypes in wearable health devices area. 
Still in Chapter 2, after this discussion regarding wearable health devices and wearable sensors, 
it is shown and analyzed a market and trends analysis of wearable health devices with the aim to 
understand which areas  of these devices will have a higher economical viability to invest in a 
near future. In the end of this Chapter, future perspectives and challenges in wearable health 
devices are covered, understanding their main barriers to overcome in the following years. 
The development phase of this Master Thesis is presented in Chapter 3. First, the proposal 
made to Biodevices, S.A. is discussed regarding the chosen scenarios and their set of sensors 
according to the previous research. Then, an estimation of the cost associated to each scenario is 
done and the decision of Biodevices, S.A. presented. The following topics of this Chapter are 
related to all the prototype development process. The next step presented is the calibration and 
validation of the sensors implemented in the developed prototype. To finalize this development 
Chapter, a new prototype is designed with some improvements and with a higher ability to 
easily integrated in Biodevices, S.A. technology, granting also a higher viability in a possible 
implementation for a possible future market expansion. 
In the final chapter of this Master Thesis, Chapter 4, some conclusions are presented such as 
suggestions for future improvements and future work, in order to achieve a prototype even 
more close to be incorporated in Biodevices, S.A. technology. 
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  Chapter 2
Wearable Health Devices 
-State of the Art and Market Trends Analysis- 
earable Health Devices (WHDs) consists in the interconnection of several modules 
that  are capable to monitoring human vital signs during a person normal day during 
work, at home, during sport activities or in a clinical environment, without interfering 
with the normal human activity and comfort [5]. 
WHDs are a specific category of personal health systems, a concept introduced in the late 90s, 
with the purpose to place the individual citizen or patients in the center of the healthcare 
delivery process, managing its own health and interacting with care providers. This has the aim 
to raise people interest about their health status, improving the quality of care and making use 
of the new technology capabilities. These devices create a synergy between multiple science 
domains such as biomedical technologies, micro and nanotechnologies, materials and electronic 
engineering and information and communication technologies. [3, 6] 
In a common situation, when a patient needs to be monitored, it is necessary for him to be 
hospitalized with expensive equipment and medical personnel on hand. Using wearable health 
devices it is possible to obtain a ubiquitous ambulatory monitoring of vital signs over extensive 
periods and outside clinical environment. This feature allows to obtain vital data during 
different daily activities than a traditional clinical acquisition, ensuring a better support in 
medical diagnosis and/or helping in a better and faster recovering from a medical intervention 
or body injury. [2] 
Wearable health devices can be used in many medical situations according to patient disease 
or rehabilitation program, but are also very useful in sport activities to monitor athlete 
performance or even in fire fighters and combatants to evaluate and monitor their body 
W 
  
 
 
Chapter 2 - Wearable Health Devices 
-State of the Art and Market Trends Analysis-  
8 
 
response in different situations. Independently of the WHD purpose there are four main 
constraints on its design: low power requirements, reliability and security, comfort and an 
adapted design for the human body. [2, 7] 
According to IHS Inc. WHDs only in fitness and wellness applications will increase 23.2% this 
year, and then will have a rate of growing of about 9% per year until 2019. The application of 
WHDs in healthcare and medical environments will growth 6% this year, but in 2019 it is 
expected to grow 10%, corresponding almost to $15 billion only in 2019. [1] 
This chapter will start with a description of WHDs generic architecture, making a division in 
several modules, discussing each one and the main variations between developed devices. Then, 
the main types of WHDs already developed are going to be introduced, including some 
commercial WHDs and recent prototypes. In this section Biodevices, S.A. and their WHD, named 
Vital Jacket®, are going to be presented and this smart t-shirt is going to be compared with other 
similar commercial products. After this, a discussion will be presented about the most needed 
physiological and ambiance parameters to be monitored in ambulatory situations concerning 
medical, personal healthcare, fitness/wellness and sport activities areas. To understand how 
WHDs market will evolve, a market and trends analysis will be presented according to the areas 
referred. In the end, a future perspective and challenges regarding the introduction of these 
devices in the community will also be discussed. 
2.1.  Generic Device Architecture   
Since the last decade, due to a higher elderly population and to the emergence of chronic 
diseases, the research interest in wearable physiological measurements devices has been 
growing, resulting in the development of many different devices. This effort is resulting in small 
wearable devices, with the benefits of a lower cost and higher mobility while the physiological 
data is being collected. [2] 
A research was done with the purpose to create the most global possible device architecture 
with features from several wearable devices already developed, such as researched prototypes 
and commercial products. The generic architecture is presented in figure 2.1.1, and is mainly 
divided in four modules. The first one is the human body that can be from a patient with a 
disease that has the need to be monitored or from a normal person with the aim, for example, to 
monitor his personal vital sings during fitness activities. Then, the vital signs are captured by 
biosensors, being this the second stage of the workflow. These sensors can also measure 
ambiance variables, capturing, for example, temperature or relative humidity of the air around 
the person. This second module of the WHD is defined as the Body Area Networks (BAN), a very 
used terminology to describe the sensors around the human body. All these electrical analog 
signs goes to a portable unit (third module), where they are processed and stored or/and sent to 
other devices, allowing vital signs monitoring in real-time during long periods. The last module 
of WHDs architecture is divided in two, online and offline monitoring. This allows the 
visualization and analysis of the captured signals in real-time or In the end of a certain period. 
The following topics will explain each of these modules from the architecture, to better 
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understand each one and its several variations according to some existing wearable health 
devices. [8, 9]  
 
Figure 2.1.1 – Generic architecture of a wearable health device. Adapted from [6, 8-11]  
2.1.1.  Patient or Normal Subject 
The use of a WHD is not only necessarily to be included in clinical cases monitoring, but also 
to be used in normal subjects, such as in fitness, wellness and sport activities, being perfectly 
adapted to all these situations. Monitoring patient’s health out of the hospital environment is 
growing due to the increase of healthcare costs and the ageing of the world population. In this 
way, WHDs can provide real-time information about health’s condition, transmitting it to a 
medical center or to a supervising professional. This enables to alert patients from a possible 
imminent health threatening independently of the place where he is. [11] 
There are several physiological signs that can be measured, gathering information with the 
aim to obtain an overall estimation of the subject health condition at any time. In order to 
understand the applicability of WHDs in patients with different diseases and in normal subjects, 
a resume approach of clinical cases where WHD can be used is going to be presented in section 3 
of this Chapter.  
According to The World Health Organization, it is expected that, in 2015, 20 million deaths 
will happen due to cardiovascular diseases (CVD), and an effort is being made to reduce this 
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number, implementing WHDs in the clinic. As Europeans guidelines on CVD refer, the best 
prevention in cardiovascular disease is to frequently monitoring blood pressure, a problem that 
WHDs can solve, using several methods as it will be discussed in section 3. Electrocardiogram 
(ECG) and blood oxygen levels measurements can be used to diagnose early signals or cardiac 
abnormalities leading to better outcomes in cardiac patients. As an example, atrial fibrillation, a 
common cardiac disorder and sometimes asymptomatic, in most patients is not diagnosed until 
worse heart conditions, like heart attack or stroke. A recent study proved that AliveCor’s, a WHD, 
has a higher sensitivity and specificity than a standard 12-Lead ECG normal device, providing 
accurate and reliable data for an earlier detection of atrial fibrillation. Respiration rate can also 
be measured to monitor coughing events and other respiratory variables. [12] 
Glucose monitoring using a WHD is a great benefit for patients who suffer from diabetes 
allowing a continuous self-monitoring, resulting in a higher patient autonomy. It also provides a 
more effective process to manage the disease, indicating the right quantity of insulin to prevent 
hypoglycemia complications. [4, 12] 
Another area where WHDs can be used is in neurological function monitoring, mainly in the 
post-operative management, outpatient care and rehabilitation areas. Here, the devices are used 
to analyze gait, limb paralyses and cerebral palsy, and have the capability of early detect 
Parkinson’s and Alzheimer disease in apparent normal patients. [12] 
In physical therapy and rehabilitation WHDs are also used to monitor patient mobility, but 
with the aim of provide objective criteria of the patient progression through therapeutic 
exercises analysis. This feature helps in the improvement of exercises techniques, minimizing 
therapeutic recovery time. With a real-time analysis device it is possible to generate alerts 
providing guidance and feedback to the patient according to the activity level and ambiance 
conditions. [4, 12] 
Beside patients, WHDs are used also in sports, mainly in highly competitive teams. The 
tracking of physiological signals and body kinematics during exercise provides information that 
helps in a better understanding of the athlete and possible improvements on his performance. 
An example is the study of how a race driver responds during simulated conditions, analyzing 
sweat and heart rate for instance. [4] 
2.1.2.  Body Area Network 
Body Area Network (BAN) is defined as the amount of sensors that acquire vital signs from 
the human body and are connected to a main unit through wires or wireless communication 
protocols. These sensors can be placed in different parts of the body and nowadays are being 
combined with textiles resulting in the so-called smart fabrics, providing a more comfortable 
and user-friendly way to monitor human body physiological parameters. [9] 
For each physiological sign referred in the previous topics, there can be one or more ways to 
measure it requiring different technologies and sensors. The following table (Table I) resumes 
some of the sensors used to measure health parameters with WHDs. The selection of these vital 
parameters was based on the most referred vital signs parameters used in developed WHDs 
present in the researched literature of this study.  
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Table I- The most used vital signs in WHDs, it source and some of the sensors technologies used to 
measure each one. Adapted from [4, 9, 11-15] 
 
The vital signs presented in the previous table, except perspiration and body and/or skin 
temperature are the main used sensors to perform three predominant data mining task in 
medical environment using WHDs: prediction, anomaly detection and diagnosis. To better 
analyze these three data mining tasks, figure 2.1.2 shows a schematic overview of these three 
processes in relation to three dimensions.  On the bottom of this figure are two main places 
where patients are monitored (Home or Clinical), where clinical settings are typically focused on 
diagnosis making. On the top of the image it is made a distinction of subjects, between healthy 
subjects or patients. On the left of the figure are presented two possible data processing 
methods, an online or an offline method. The figure also present a subtask named Alarm, mainly 
used in patients, facilitating independent living in home environments and increasing the sense 
of security. [16] 
 
Type of Bio-signal Signal Source Type of sensor 
Electrocardiogram (ECG) Electrical activity of the heart -Skin/chest electrodes 
Heart Rate (HR) Frequency of the heart cycle 
-Pulse oximeter 
-Skin electrodes 
-Optical 
-Radio-frequency identification 
-Phonocardiograph 
Blood pressure (systolic 
and diastolic) (BP) 
Force exerted by circulating 
blood on the walls of blood 
vessels, especially in arteries. 
-Ultrasound 
-Arm cuff-based monitor 
Blood oxygen saturation 
(SpO2) 
Oxy-hemoglobin that is being 
transported in blood vessels.  
-Pulse oximeter 
Respiration Rate (RR) 
Chest movement giving 
inspiration and expiration per 
unit time   
-Elastomeric, impedance and 
respiratory inductive 
plethysmography 
-Extracted from ECG 
Blood Glucose (BG) 
Amount of glucose (main 
type/source of sugar/energy) 
in blood 
-Strip-based glucose meters 
-Ocular glucose meter 
-Tissue glucose meter 
Perspiration or skin 
conductivity  
Sweat glands activity which is 
associated with skin electrical 
conductivity 
-Woven metal electrodes 
-Electrochemical electrodes 
Body and/or Skin 
temperature  
Body and/or skin temperature 
-Temperature probe 
-Skin patch 
-Radio-frequency identification 
-Optical Infrared thermometer 
  
 
 
Chapter 2 - Wearable Health Devices 
-State of the Art and Market Trends Analysis-  
12 
 
 
Figure 2.1.2- Schematic overview of the main three data mining processes (prediction, anomaly 
detection and diagnose/decision making) in relation to different aspects of wearable sensing in 
wearable health devices. Adapted from [16]. 
Prediction area consists in the identification of events which haven’t occurred yet, providing 
medical information to help in the prevention of further chronic problems, leading sometimes to 
a decision about the diagnosis. Anomaly detection is responsible for the identification of unusual 
patterns that are not conformed to the expected behavior, being based on classification methods 
to distinguish normal data from outlier data, such as irregular patterns in ECG waveform or in 
SpO2 signal for example. The alarm subtask is mainly used in anomalies detection, raising an 
alarm as soon as an anomaly is detected. Diagnose is one of the most important tasks of clinical 
monitoring, resulting in a clinical decision according to retrieved knowledge of vital sings, health 
records and anomaly detection data. [16] 
To analyze the research that is actually being made with WHDs in each of these data mining 
tasks it is presented in the figure 2.1.3 the number of papers publish related to wearable 
sensors, based on those three data mining task and according to the considerations made in the 
literature [16]. In this figure (Figure 2.1.3) it is possible to evaluate in which wearable sensors 
has been made a higher study and a higher effort to obtain reliable sensors for medical 
applications, predicting that exist a higher effort in ECG, heart rate and respiration rate sensors 
development. The fact that ECG and heart rate are the main used wearable sensor is important 
because they emphasizes the huge importance of Vital Jacket® in medical applications, since it 
measures ECG signal from where it is also possible to obtain heart rate measurements. 
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Figure 2.1.3- Number of scientific papers published according to the most six used wearable sensors 
in WHD’s, with a distribution  of the presented data mining task for each one. Adapted from [16]. 
These vital signs parameters are based on the most used vital sign monitored in WHDs 
according to the literature. In section 3 of this Chapter it will be made a deeper discussion about 
vital parameters, but with a selection based on the needs in ambulatory monitoring of patients 
from a medical point of view and also based on society needs to improve their life healthcare. 
2.1.3.  Portable Unit 
The Portable Unit (PU), also denominated as user interface box or datalogger, is where all the 
information is gathered, containing the outputs and inputs of the WHDs. The main inputs are the 
vital signs from sensors, but it can also receive data from connected portable devices. 
The communication between sensors and the PU is normally made through wires, resulting in 
a simpler and cheaper WHD. Some variations in this communication technique have been 
emerged, such as in smart clothes, where the interconnections (wires) are embedded and woven 
into the fabrics. This is a much more favorable approach in WHDs, avoiding loose wires around 
the body leading to a higher comfort and movement liberty. There is an innovative approach 
where the communication is made through biological channels, where the human body is used 
as a transmitter using electrostatic fields. [2] 
 The PU receives the analogic vital signs where the signal can be amplified and/or filtered, 
converting then it to a digital signal. This process can also be made outside PU, consisting in an 
optical sensor array with integrated analog-to-digital convertors.  
Signal processing can be made in the PU or in other device after data transmission to it. This 
processing extracts features to evaluate the subject health, allowing the detection of an anomaly, 
a disease prediction or helping in diagnoses. 
Then, data in the PU can be transmitted or storage, for example by wireless protocol or in a 
SD memory card, respectively. As it can be seen in figure 2.1.1, PU can also receive data from 
online monitoring devices storing it. This receiving process from other devices allows the 
storage of possible sensor data from external connected devices, reducing the number of 
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wearable sensors needed in the WHD. This communication is normally performed by one of the 
three wireless communication protocols: Bluetooth, Wi-Fi or ZigBee. [2, 8, 11] 
Bluetooth is a short-range radiofrequency based connectivity between portables and also 
fixed devices requiring low-power and with a low-cost consumption. It is ideal for WHDs and 
widely implemented in commercial devices like smartphones or laptops. Wi-Fi protocol lower 
layers were adopted, allowing higher data throughput for low power requirements applications, 
being also a good connection protocol to use in WHDs. ZigBee is another technology used for low 
power and low data rate communication protected by the use of the Advanced Encryption 
Standard. This feature makes ZigBee ideal to medical applications with the advantage of 
consume much less energy than Bluetooth, but with a lower data transferring rate. Mobile 
telecommunications technologies can also be used to transmit real-time data using GPRS, a 
standard mobile data service in the global mobile communication. [2, 8, 11] 
In offline cases the data transferring can be perform by reading the SD memory card or, if 
possible, through a USB connection between the WHD and another device, where data from the 
SD card is transferred. 
In the next two topics it will be presented two possible types of ambulatory monitoring, 
online/real-time and offline, referring the main different situations where they can be used.  
2.1.4.  Real-time Monitoring 
A higher need of monitor patients during long periods in the hospital led to a real-time 
monitoring, providing health condition feedback at any time. With WHDs it is possible to have 
this monitoring outside a medical environment, alerting the patient in case of any physiological 
problem or just to monitor himself and be updated of his vital signs during daily activities. [11] 
In a medical environment WHDs allows the patients monitoring inside the boundaries of a 
specific area, normally a Hospital, where the patients can move while their vital information is 
being wirelessly transmitted to a remote monitoring center. Some devices also send the patient 
location. All these features allow the patient to move without any machines with him instead of 
being laid in the Hospital bed. In these live systems it can also be configured a set of alarms for 
each patient helping in the detection of some required anomaly. This type of monitoring systems 
are defined by the literature as “Controlled Area” and “Wide Area” systems and always has a 
medical specialist to provide information to the patients if needed. The vital signs can also be 
recorded in Medical Information Systems to be later analyzed by a doctor. [8, 17] 
The biggest advantage of WHDs is the real-time monitoring in the patient’s home and 
outdoors, according to preventive medicine protocols, normally using regular Internet 
communications at home and mobile technologies in the outdoor. This feature allows the patient 
to have a normal life while is being monitored, being his vital signs continuously or 
intermittently transmitted to a remote monitoring center, with health support and, if needed, 
inform the patient of his medical status. The ambiance data is also important to know the 
conditions which people are exposed. For example, if an elderly person is subjected to an 
excessive cold or hot weather that can cause lung infection, dehydration or other diseases, a 
therapy can be immediately initiated, preventing a dangerous situation. [4, 8]  
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For last, vital signs can also be transmitted via Bluetooth to portable devices or personal 
computers to visualize and analyze the health status of an individual. This type of real-time 
monitoring can be used in sport activities to analyze the athlete vital signs during exercise, or in 
a simple daily run. This type of system is referred in the literature as “Wide Areas” and “Self-
Monitoring” due to the non-involvement of medical specialists. Another example is the use of 
these devices in the health status monitoring of firefighters and combatants in field using mobile 
technologies, such as GPRS. [8, 10] 
2.1.5.  Offline Monitoring 
All the data from vital signs can be stored in the storage of the portable unit (SD memory card 
for example), being then used for medical analysis or just for personal record. The data can be 
stored at the same time that a real-time monitoring is occurring, saving the data for a later 
analysis of vital sings. The main aim of these monitoring is to record vital data for clinic 
diagnosis and prediction by a medical specialists. For example, sleep issues such as apnea, can 
be analyzed through saved data from the patient, allowing him to sleep at home, a familiar 
environment, acquiring a higher reliable data. [10, 16]  
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2.2.  Wearable Health Devices Developed 
Wearable health devices are becoming important ambulatory monitoring systems helping in 
medical prediction, anomaly detection and diagnose (Figure 2.2.1). One of the problems is the 
limited number of measured physiological parameters. Many WHDs are developed with the aim 
to measure only one physiological sign, adapting it design and use to that only parameter. This 
fact results in several WHDs able to monitor a certain amount of vital parameters, but with 
monitoring limitations. 
Wristwatches, also known as smartwatches, are under development for a few years. One of 
the first’s devices of this type was AMON, first presented in 2002 and capable of monitoring 
heart rate, blood oxygen saturation and skin temperature, already with a wireless data 
communication module [18]. More recently, a new smartwatches generation is emerging with 
wireless and mobile communication, able to provide more than 24 hours of vital monitoring 
[19]. Their comfortable design, similar to a normal watch, allows to worn it constantly. These are 
being developed as activity and fitness trackers, monitoring physical activity like burned calories 
and distance traveled, heart rate, and, more recently, sleep monitoring, like PEAKTM which is the 
first smartwatch able to track sleeping cycles [20, 21].   
 
Figure 2.2.1- Examples of wearable medical devices and prototypes. From the top in clockwise: a new 
ear prototype to measure several physiological parameters; smartwatch Basis PEAK TM [21];a finger ring 
prototype for plethysmography; an ECG BioModule (BioPatch TM)attached to normal electrodes in the 
chest [22]; a prototype jacket with several sensors; a wrist-worn device (AMON); and a chest belt to 
measure respiration rate and ECG (Bmedical®). Adapted from [4, 23, 24] 
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Finger sensors, as rings, have also been developed, but with the only propose to use 
photopletysmography (PPG) technology to measure blood oxygen saturation, not being a viable 
human body place to monitor other vital signs. Armbands and chest belts are more capable to 
acquire several vital signs, but they are not so comfortable and easy to wear as a simple part of 
clothing, being denominated as accessories [4, 23]. Another accessory device was recently 
developed with a “special form optical PPG sensor” to be used in the human ear, being able to 
measure and estimate several physiological parameters, like oxygen saturation level and heart 
rate [24].  
Sensors embedded in the user outfit as parts of clothing, more known as smart clothes, are 
the best bet to acquire a higher amount of physiological signals. Vital Jacket® is one of these 
cases; it is a t-shirt with embedded electronics, capable to monitor ECG signal and heart rate. 
With the aim to analyze developed WHDs similar with Vital Jacket® technology, the following 
discussion will present Biodevices, S.A. and their WHD, such as similar WHDs commercially 
available and recent prototypes of smart clothes that are being developed. 
2.2.1.  Biodevices, S.A. 
Biodevices, S.A. was born as a spin-off in Aveiro University at IEETA (Instituto de Engenharia 
Electronica e telemática de Aveiro). Their mission is to “develop, commercialize and export 
biomedical engineering solutions for medical diagnose”. All started with the Vital Jacket® project 
in 2002, when it was only a prototype capable of measuring several vital signs. To turn this 
prototype into a commercial high tech textile medical device Biodevices, S.A. was created and, 
along with Petratex S.A. for the textile development, Vital Jacket® as a product was developed 
and launched in the market. Vital Jacket® is the first certified medical device of its kind and 
nowadays is considered an added value in clinical daily work. It is certified according the MDD 
93/42/EEC, holding the CE mark and is also certified under standards ISO 9001 and ISO 13485 
as a medical “Ambulatory ECG device”. It has also Brazil Certification according to ANATEL and 
ANVISA regulations. [10, 25] 
In the following section, a Vital Jacket® device description will be made, regarding its 
characteristics, sensors and applications. 
2.2.1.1.  Vital Jacket® Wearable Health Device 
Vital Jacket® (Figure 2.2.2) is a smart cloth with a wearable vital sign monitoring device, 
designed and developed with the aim to have a practical approach for several clinical scenarios, 
such as in hospitals, at home or during movement, where a continuous or frequent cardiologic 
monitoring is required. This t-shirt with embedded electronics can acquire 1, 3 or 5 ECG leads 
using gel electrodes up to 7 days and it is totally washable. The data is collected in a small and 
lightweight portable unit (66x38x16 mm) that fits easily in the t-shirt pocket, being used for 
adult and pediatric ambulatory ECG acquisition in cardiac rehabilitation, sport medicine and 
occupational medicine. It is equipped with a Bluetooth transmitter which enables the 
  
 
 
Chapter 2 - Wearable Health Devices 
-State of the Art and Market Trends Analysis-  
18 
 
visualization of ECG signal in real-time, saving the data, at the same time, in a SD memory card 
for a possible offline monitoring if necessary. This characteristic also allows to send the signal 
remotely to another location using either a computer, personal digital assistant, smartphone or 
tablet with internet connection. With this option, Vital Jacket® can be used in telemetry systems 
and remote monitoring, enabling physicians to follow their patients. Vital Jacket® portable unit is 
equipped with a 3-axis accelerometer allowing to evaluate patient or normal subjects’ 
movement intensity. [10, 26] 
 
Figure 2.2.2- Vital Jacket® product. Beside T-shirt and portable unit, it comes with a software to 
analyze ECG, a portable unit charger and gel electrodes.  Adapted from [25] 
In order to perform real-time monitoring and signal analysis, Biodevices, S.A. has also several 
developed software, such as VJ Holter Pro that automatically analysis, identify and separate ECG 
signals by class and morphology and Vital Jacket® Cardiac Rehabilitation System to receive ECG 
signals through internet connection and analysis it in real-time or In the end of the training. [10, 
26] 
Vital Jacket® device architecture shows a comfortable and reliable ambulatory ECG device to 
monitor adult patients, children or athletes during their daily life activities. Beside the 
characteristics already referred, this device can be adapted to acquire other different vital signs 
(temperature, respiration, movement/fall, posture, blood oxygen saturation) and psyco-social 
variables (panic button, medication delivery, activity habits, location) as cited by developers. 
These new signals can be embedded in the t-shirt or acquired from other devices through 
Bluetooth connection, saving all the data in the SD memory card. [10, 26] 
To better understand what is already developed worldwide in this area of smart t-shirts, the 
following sections will present WHDs similar to Vital Jacket® device and also some of the most 
recent prototypes developed. 
2.2.2.  Commercial Wearable Health Devices Available 
There are not many commercial WHDs based on smart clothes for ambulatory monitoring. 
Beyond Vital Jacket®, nowadays there are about four commercial products that are able to 
provide ECG signal, where only three have CE mark certificate, and just one is certified with the 
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Medical Device Directive (MDD) 93/42/EEC and under standards ISO 13485 and ISO 9001, like 
Vital Jacket®. These three CE mark certified WHDs are nECG TEXTILE, the only certified as 
medical device, from Nuubo® [27], Smartex Wearable Wellness System from Vivonoetics® [28] 
and hWearTM from HealthWatch [29], the only one with Food and Drug Administration (FDA) 
approval (Figure 2.2.2). Hexoskin® [30] is a WHD smart T-shirt capable of acquire ECG signal, 
but without CE mark and medical device certification. Vivonoetics® WHD and Hexoskin® also 
can monitor respiratory signals. All these WHDs communicate with mobile devices using 
Bluetooth communication protocol and have applications to provide real-time vital parameters 
measurements to the user.  
a) 
   
b) 
 
c)  
 
Figure 2.2.3- Smart shirts for ambulatory monitoring with CE approval. a) nECG TEXTILE from 
Nuubo® (MDD 93/42/EEC, ISO13485, ISO9001) [27]; b) Smartex Wearable Wellness System from 
Vivonoetics® [28]; c) hWearTM from HealthWatch (FDA approval) [29]. 
Several more wearable smart clothes are commercialized, but do not acquire ECG, only heart 
rate and some other physiological parameters like respiration rate, being mainly used in sports 
physical evaluation and also sleep monitoring. For example, there are BioManTM from AiQ Smart 
Clothing Inc. [31], OMsignal Biometric Smartwear from OMsignal Inc. [32] and BioHarnessTM 3 
from ZephyrTM [22], all capable to communicating with mobile devices via Bluetooth and also 
with their own application, to give human body vital information to the user.  
2.2.3.  Recent Prototypes 
In this topic it will be only presented the most recent WHDs prototypes (since 2010, 
including) which are similar to Vital Jacket®. 
In 2010 it was presented the LOBIN device, a physiological monitor of ECG, heart rate, angle 
of inclination, activity index and body temperature monitoring, tracking the location of the 
patients within the hospital. This device can store and transmit wirelessly vital data, supporting 
the configuration of alarms by setting different triggers for each patient. With LOBIN it was 
possible to monitor patient health status in real-time easily using a graphical user interface, 
which allowed the monitoring of several patients at the same time in the same screen, 
independently of the patient location. [8] 
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The Sensing Shirt was prototype proposed in 2011 by Zheng-Bo Zhang et al. [33], a device 
capable to acquire basic cardiopulmonary parameters such as ECG, abdominal and chest 
respiration, and blood oxygen saturation using PPG. All sensors, except PPG, are integrated in 
the shirt fabric and connected to a data acquisition unit by wires also integrated in the fabric. 
PPG sensor can be placed at the index finger/ear lobe and is plugged to the data acquisition unit 
through a cable and secure connector. This device has a 3-axis accelerometer to record body 
posture and activity, storing all the collected data in a micro SD memory card. In 2011 it was also 
presented a multi-parameter wireless shirt to monitor ECG, heart rate and respiratory rate by 
Emilio Sardini et al. [34], with a communication channel for remote assistance. This device has 
contactless ECG electrodes to avoid gels and skin irritations and all the data is transmitted by 
Bluetooth to a PC, bing visualized or sent via internet for remote assistance. The authors defend 
the use of this device to home telemonitoring, evaluating vital parameters of the patient and his 
activity using a 3-axis accelerometer. 
More recently, in 2013, a different sensorized shirt was presented by Amer Farjadian et al. 
[35], named SQUID. This prototype was developed with the aim of home rehabilitation to 
monitor and evaluate physical therapy exercise with an online database for therapist’s remote 
supervision from Hospital. Although it does not monitor ECG, it can monitor muscle activity 
using electromyography and heart rate, being capable to create an objective biofeedback so as to 
guide the user to follow the correct procedure as prescribed by the physical therapist. 
One of the most recent prototypes was developed by Carmela Cafagna et al. [36] in 2014, and 
it is called MyWear. This smart T-shirt device as the disadvantage to measures only the heart 
rate, concerning heart monitoring, but it has an innovative respiration rate measuring 
technology. This is based on PolyPower, a recent polymer that changes it conductivity when 
stretch. It also has a fall detection system and a plantar pressure distribution system in a shoe. 
These systems can connect to a smartphone for real-time monitoring functionalities and 
features visualization. Future research has the aim to validate the developed technology and 
platform. 
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2.3.  Wearable Sensing of Physiological and Ambiance 
Parameters 
In this section, physiological parameters measured nowadays using WHDs are going to be 
presented. In order to understand why those vital parameters are the most common used in 
WHDs, it is important to analyze the medical perspective concerning vital signs used to 
ambulatory monitoring. This section will focus on the physiological parameters that are 
medically considered as vital signs and has a relevant importance in health monitoring. This will 
allow us to conclude if the already referred physiological signals are relevant and why, and if 
there are more physiological parameters that can also be important to obtain a more complete 
health monitoring. Some ambiance parameters are also discussed evaluating their contribution 
in health monitoring.  The information needed for this section was collected from a research 
based on medical protocols and medical journals, as also in ambulatory healthcare needs, 
diseases and human activities. 
To evaluate each physiological parameter, it is important to define first the most important 
vital signs measured in medical healthcare. This is a relevant problem because there are several 
opinions of which vital signs should be measured to identify clinical deterioration. There are five 
traditional vital signs that have a major importance to be measured: heart rate, blood pressure, 
respiratory rate, blood oxygen saturation and body temperature. These five signals are essential 
to evaluate human health and a continuous monitoring should be made, mainly in patients. 
Thomas Ahrens in [37] presented two more vital signs that he consider important to be 
immediately measured if the patient is in any danger, which are capnography and stroke 
volume. More recently, Malcolm Elliott and Alysia Coventry in [38] described another three 
important vital signs that should also be considered as part of routine patient assessment, such 
as pain, level of consciousness and urine output. According to these authors, the union of these 
five signals with the five essential ones referred allows to obtain an accurate recognition of 
changes in patient’s physiology.  
Although it is not referred, ECG will also be referred due to its major importance in heart 
electrical analysis, fact very important to predict and diagnose cardiovascular diseases. [39] 
Diabetes mellitus is a disorder that must be carefully discussed in order to understand the 
huge effort in research that has being made to develop non-invasive methods to monitoring  
glucose levels. [4, 12] 
Beside these medical parameters there are other parameters that are also important to 
monitoring in order to evaluate neurological function, rehabilitation procedures, posture, 
motion control and sports performance, such as skin perspiration. [4, 12] 
In this chapter, nine physiological parameters were chosen to be independently discussed 
with the aim to understand their medical and health importance in ambulatory monitoring. 
Some of the main diseases which require continuous monitoring are going to be presented, as 
also some of the main technologies to acquire these parameters. The physiological parameters 
are going to be the five essential ones and four more: ECG ambulatory monitoring; Glucose level 
monitoring due to its relevance in society needs; Capnography, a method to evaluate physiologic 
ventilation; and skin perspiration, a physiological parameter involved in several human 
activities and behavior, such as in sport, emotions and stress. [4, 12] The remaining 
  
 
 
Chapter 2 - Wearable Health Devices 
-State of the Art and Market Trends Analysis-  
22 
 
physiologicparameters referred will also be discussed in a single topic, named “Other 
physiological parameters”. 
After the discussion of physiological parameters, ambiance parameters will be briefly 
discussed, to analyze their importance in human health monitoring. 
2.3.1.  Electrocardiogram 
Electrocardiogram (ECG) is one of the most widely used biosignals, as a diagnostic tool in 
healthcare environment, providing information of the cardiac cycle. It is used to analyze the 
cardiac rhythm, ischemic changes and early prediction and treatment of acute myocardial 
infraction and coronary events. ECG signal is the most common technique to measure heart 
electrical activity. 
Its patterns changing analysis are used in the diagnose of cardiovascular diseases (CVD), such 
as angina, atherosclerosis, cardiac dysrhythmia, congestive heart failures (CHF), coronary artery 
disease, heart attack and tachycardia. ECG signal is basically a spectrum of the heart 
bioelectricity, where it can measure the depolarization (contraction) and repolarization 
(relaxation) of the cardiac muscle cells (Figure 2.3.1). [39] 
 
Figure 2.3.1- Illustration of an ECG heart cycle, with the characteristic oscillations due to the cardiac 
electrical activity. It is constituted by: a baseline -starting point of the electrical activity; P wave-
auricular depolarization (0.11 s; 0.15 mV); P-R segment- Delay time between auricular-ventricular 
nodule (heart pacemaker) and ventricles (0.12 a 0.20 s); QRS complex -Ventricular depolarization, where 
ventricular contraction starts and auricles repolarize (0.09 s; 1.1 mV); S -T segment-temporal region 
where ventricles are uniformly depolarized (0.05 a 0.15 s); T wave-ventricular repolarization (0.2 s; 0.2 
mV). Adapted from [40]. 
To measure these bioelectric changes in heart muscle cells are used electrodes. These sensors 
transduce ionic current skin into electron current in metallic wires, and their characteristics 
have in consideration cells low electrical potential difference (from -40 to -80 mV) and also skin 
impedance. The commonly-used electrodes in clinical are wet electrodes, based on Ag/AgCl, 
which contacts with the skin using a gel to improve skin contact. These electrodes are very 
reliable, compact and low cost, but causes skin irritation due to adhesives properties. During 
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long acquisitions the gel dries, reducing the contact with skin. To obtain longer acquisitions, 
holters are normally used, but with the main disadvantage of interrupt daily routine, not being 
feasible for unobtrusive continuous monitoring. To overcome this problem, dry electrodes and 
embedded wires in the fabrics are being developed using several materials. This type of 
electrodes has the main advantage of causing no skin irritation, but, as they are not adhesive, 
artifacts appear due to body movement. [2, 39] 
In order to reduce the artifacts produced by body movement and skin irritation, Ningqi Luo et 
al. [41] developed a new technology of dry sensors that are flexible and stretchable, but with the 
disadvantage of being attached to the human skin, making it not very viable to use out-side the 
medical diagnose monitoring. 
A possibility to overcome the adhesive properties is to have a dry electrode without adhesive 
properties resulting in proper electrodes for wearable applications. Yu Chin et al. developed a 
wearable, unobtrusive and patient friendly sensor that is able to acquire ECG signals through 
insulation such as fabric, being this technology firstly reported in 1969. Wearable electrodes are 
being embedded in textile fabrics where the fiber must be electrically conductive with low 
current and low impedance. These types of electrodes are normally a bundle of a normal fiber 
filament, like nylon, that is electrochemically plated with a metal. The fiber used in its fabrication 
must undergo several actions as stretching, bending and twisting, in order to adapt to the body 
movement, and to be washable. [39] 
2.3.2.  Heart Rate 
Heart rate (HR) is a standard vital sign and has become a routine measurement practice in 
general healthcare units. The monitoring of this signal provides information about specific 
physiologic status indicating changes in the heart cycle. The heart rate indicates the frequency of 
a heart cycle and is conventionally presented in cycles/beats per minute. This vital sign can be 
easily calculated from ECG or PPG signal, or it can be measured with characteristic sensors with 
the aim to only measure heart rate. HR is also simple to measure directly from the human body 
with no need to be calculated, informing of some cardiovascular parameters. HR is also very 
important in sport and activity context to evaluate or inform heart response to exercise and 
recovery. Heart rate variability analysis is gaining attention as an indicator of the health status of 
the cardiovascular system. [4, 23, 37] 
Medical specialists propose other measurement related to heart rate that can substitute it, an 
important vital sign named pulse. This parameter is defined as the palpable rhythmic expansion 
of an artery produced by the increase of volume of blood pushed into the vessel by the 
contraction and relation of the heart, providing further than HR, such as strength or amplitude of 
the pulse and it regularity. A problem referred in the literature regarding the use of this 
technology is the decrease of blood volume in case of an irregular pulse or hypovolemia. This is a 
real problem that has not been solved yet, even though it is easy to overtake. It should not be 
considered the same as heart rate and it can be determined using pulse oximeter, the same 
method used to measure blood oxygen saturation. [38] 
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2.3.3.  Blood Pressure 
Blood pressure (BP) vital sign is considered the most important cardiopulmonary parameter, 
indicating the pressure exerted by blood against the arterial wall. It provides information about 
the blood flow when the heart is contracting (systole) and relaxing (diastole) and can also 
indicate cellular oxygen delivery. It is influenced by cardiac output, peripheral vascular 
resistance, blood volume and viscosity as well as vessel wall elasticity. [38, 42]  
Ambulatory BP monitoring allows to collect BP readings several times at any hour across a 
24-hour period. This is ideal to monitoring high blood pressure (hypertension) which is one of 
the greatest threats to the global burden of diseases. Hypertension diagnose require BP 
measurements and it accuracy can increase with ambulatory monitoring, increasing also the 
prediction of cardiovascular risk. There are three main BP problems related to hypertension that 
can be resolved with ambulatory monitoring. First one is normally, during sleep, blood pressure 
decrease in such way that it average is lower than average awake blood pressure. When it 
decreases more than 10% the individuals are called non-dippers and this problem affects about 
70% of the population. A nocturnal hypertension and a non-dipper pattern are associated with 
the increased of cardiovascular morbidity and mortality, problem that can be easily diagnosed 
with BP ambulatory monitoring. Another problem is the white-coat hypertension: individuals 
who are not taking antihypertensive medication show an elevated BP in a clinical setting, and a 
normal one when assessed by ambulatory BP monitoring, a problem that occurs in 15% to 30% 
of individuals with clinical high BP. This may lead to a misdiagnosis, leading to unnecessary 
medications with potentially seriously debilitation side effects. The third main problem is the 
masked hypertension, the opposite phenomenon of white-coat hypertension and also affects 
15% to 30% of adults with non-elevated clinical BP. [38, 43]  
Regarding BP measurement, traditionally it is made using inflatable pressure cuffs with 
stethoscope on the patient’s arm. This method was adapted to be performed autonomous BP 
measurement, including a fully automated inflatable cuff that measure BP by relating external 
pressure with the magnitude of arterial volume pulsations.  [2] 
Continuous monitoring with a cuff can result in unwanted side effects, such as sleep 
disruption, skin irritations and an increase in stress levels. With the aim to solve this problem, 
new technologies to ambulatory BP monitoring have been developed [2]. A developed method 
uses a BP estimation based on pulse wave transit time between the pulse wave obtained by PPG 
and the ECG, both measured on the chest [44]. This method has already been used, but with a 
PPG signal acquired on the wrist [12]. Yu-Pin Hsu and Darrin J. Young in [45] developed a BP 
measurement new technique based also in pulse wave velocity, but using two 
microeletromechanical sensors placed in two adjacent points of the body: in wrist or neck. More 
recently, Sung Hun Woo et al. in [46] proposed an experimental watch-type prototype which 
uses a pressure sensor near the radial artery, giving an accurate blood pressure measurement 
on a personal smart phone, a real-time continuous monitoring BP wearable device. 
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2.3.4.  Respiration Rate 
Respiration rate (RR) is a fundamental physiologic parameter in patient’s observation, being 
accurate and carrying important health information, such as in case of acidosis. In critical 
illnesses this is one of the most sensitive indicators, also being an important sign of distress and 
potential hypoxemia. Malcoln Elliot and Alysia Convetry refer the following important 
statement: “respiratory rate is often not recorded in clinical settings or is simply guessed”. This 
is a major problem since RR is the best predictor of adverse events like cardiac arrest. In the 
medical environment, normally, blood oxygen saturation is assumed as a reflection of RR, and 
this is not measured, also due to the inexistence of an automated machine capable acquire RR 
sign. When measured, using traditional methods (observation of the patient respiration during 
30s), a classification is made according to the pattern observed, and can be classified as eupnoea, 
tachypnoea, bradypnoea and hypopnoea. Respiratory rate ambulatory monitoring is also 
important in the detection of symptoms of respiratory diseases such as sleep apnea syndrome, 
chronic obstructive pulmonary disease and asthma, facilitating the administration of treatments 
if needed. This constant monitoring is particularly important in children with pulmonary 
diseases. [4, 38] 
This vital parameter is normally calculated from an acquired function (respiratory 
waveform) that reflects the chest volume variation due to the inspiration and expiration (Figure 
2.3.2). From this function it is also important to obtain the thoracic expansion and, with muscle 
signs, calculate the respirator effort, which can indicate different physiological states. 
Respiratory effort can also be obtained by measuring changes in chest and abdominal volume, 
also known as plethysmography. The analysis of this vital function can also help in sport, mainly 
in competitive athletes with the aim to achieve a better respiratory performance. [4, 23, 38]  
 
Figure 2.3.2- Respiratory waveform obtained from both chest movement (RC wave) and abdominal 
movement (AB wave). It is possible to observe a normal respiration waveform at the beginning and end 
of the image, and at the middle is it represent a stimulation of an airway obstruction where a subject 
closes his mouth and attempt to take in air by moving his abdomen in a nd out, a common test in the 
respiratory evaluation. Adapted from [47]. 
To obtain RR waveform, the variation of the chest volume, and if needed also abdominal 
volume, are measured as already referred. Nowadays, to obtain this function, there are three 
primary methods: Elastomeric plethysmography, impedance plethysmography and respiratory 
inductive plethysmography (RIP). Elastomeric technique converts current variation of piezo-
electric sensors in an elastic belt to voltage. Li Guo et al. [48] developed a prototype garment 
based on this technology, capable to measure chest and abdominal volume changes with high 
accuracy, using a piezoresistive fabric sensor. The impedance plethysmography uses impedance 
changes of the body surface due to the expansion and contraction during breathing. Weak 
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alternating electrical current is applied to the body and measured with other sensor, allowing 
the body impedance to change measurement, obtaining a qualitative measurement of breath 
movement. This technology was used in the development of a uniform vest to be used in both 
soldiers and command [7].  RIP technology principle is based on the application of a current 
applied to a loop wire which generates a magnetic field normal to the loop orientation. Chest 
volume variations change the area enclosed by the loop, creating an opposing and directly 
proportional current [49]. Very recently, Ozgur Atalay et al. [50] presented a textile-based 
sensor with a conductive yarn embed in the fabric in a loop geometry. Using additional signal 
processing they were able to eliminate unwanted interferences from the breathing signal, such 
as body motion artefacts. 
Beside these three primary methods, other technologies are also being used to obtain 
respiratory waveform: accelerometers [51]; extracted from ECG signal [15]; polymer-based 
transducers sensors [52]; optical fibers attenuation due to the chest movement [53]; most 
recently, using a polymer named Polypower. This dielectric active polymer (DEAP) is being 
commercially produced as Polypower and changes its electrical attenuation when stretch in one 
direction. Tognarelli et al. [54]are using this technology to obtain chest volume variations, 
demonstrating the potentiality of DEAP in this type of physiologic measurements. 
2.3.5.  Blood Oxygen Saturation 
Blood oxygen saturation (SpO2) is an extremely valuable vital parameter and easy to measure 
using PPG technology and pulse oximetry principles (Figure 2.3.3). It indicates the amount of 
oxygen that is being carried by blood cells and normally is between 95% and 100%. This 
measure may lead to a change detection in a patient condition that could otherwise be missed, 
resulting in a changed of patient management. For example, a lower percentage of oxygen 
(<95%) can indicate hypoxemia, causing an insufficient oxygen supply to the human body. One 
of the problems in blood oxygen saturation measurement in clinical environment is when the 
patient is anemic, a reduction of red blood cells or a lower ability of these cells in oxygen 
transportation. [38, 42] 
Besides medical use, pulse oximetry ambulatory monitoring has a particular interest in the 
evaluation of aerobic efficiency of a person undertaking an exercise routine. A study about the 
oxygenation of capillary bed from muscles can lead to a maximization of the athlete 
performance. Limb and brain oxygenation information is also important in military and space 
applications, where gravity changes may affect the delivery of oxygen to these parts of the body, 
leading to blackouts. It has been discovered that exist a positive correlation between a 
individual’s performance and oxygenation responses as a function of task load. [23] 
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Figure 2.3.3- The figure represent the variation in light attenuation by tissue on colored part, and the 
PPG signal waveform conventionally representation. The PPG signal obtained depends of the absorptio n 
process and is composed by a Direct Current (DC) and Alternating Current (AC) components as shown in 
this figure. The DC component represents the transmitted or reflected signal from the tissue and 
depends of tissue structure and average blood volume of both arterial and  venous blood. The AC 
component shows the blood volume variations that occurs between systolic and diastolic phases, being 
it fundamental frequency dependent of the heart rate. Adapted from [42]. 
There are several noninvasive technologies to measure blood oxygen saturation that can be 
applied to wearable devices, but PPG stands out, being very popular in medical environment 
[42]. This technology is based on the absorbance variation of blood cells at two wavelengths, 
normally using Light-Emitting Diodes (LEDs). There are two main modes, a reflectance mode 
and an emitting mode, and it can be applied to several body parts to evaluate blood oxygen 
saturation and is normally used in microvascular bed of the tissue. Since this sensor was one of 
the chosen one to be implemented in the developed prototype, a further research is presented in 
Chapter 3 to better understand the theoretical fundaments behind this technology. 
The finger is the most used place to acquire blood oxygen saturation levels and is the most 
used in clinic conditions. Ring PPG sensors are under development due to its more wearing-
comfortability and easily adaptation. Mobile connections improve these sensors to a much more 
independent and wearable device [55]. Ear lobe can also be used and a recent research 
presented a very small chip (3x6mm2) capable of measure blood oxygen saturation, with the aim 
to be used in future wearable devices. Forehead is also used to measure brain oxygenation and 
has already been developed as described in the literature [56]. A surface chest PPG reflectance 
prototype device was developed by Sawa Puke et al. [44] demonstrating the viability of oxygen 
continuous monitoring in this body location. Recent developments made by Chen et al. [57] 
allows adjust PPG sensor parameters to refine the depth of tissue measurement, enabling 
several body sensor location possibilities and improving its functionality for clinical 
applications. 
Concerning textile technology, there is being a huge effort to implement PPG sensors in this 
area. Different approaches using textile fabrics have been intensively studied in recent years. 
One of these approaches is based on the integration of flexible plastic strips in weft direction: 
two LEDs strips and two photodiode strips, with cooper wires in the textile to conduct the signal 
in the textile fiber [58]. Another approach, and a very recent one, is the use of optical fibers 
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embroidered into textile. Marek Krehel et al. [59] developed this new textile technology, which is 
capable to analyze different depths of tissue using a ring design in the optical detection of the 
reflected light. This detection and the light-source are both made using optical fibers. 
2.3.6.  Blood Glucose 
Blood glucose (BG) is a worldwide need measurement in diabetic’s persons. Although this 
parameter is not measured in a normal procedure of a clinical environment, it is an important 
measurement in diabetic global population. According to World Health Organization, in 2014 it 
was estimated that 9% of the worldwide population among adults aged above 18 had diabetes 
and in 2012 it was estimated 1.5 million deaths directly caused by this disorder. Diabetes 
disease causes several physiological disorders such as cerebral vascular disturbance, 
retinopathy and nephropathy. To prevent these complications, diabetic individuals control their 
blood glucose concentration measuring BG levels and injecting insulin when needed to 
maintaining the standard values. The most used method to evaluate BG concentration is 
collecting a blood sample by pricking the finger with a lancet. This invasive technique is not the 
best way to continuous monitoring blood glucose and to resolve this problem non-invasive 
techniques were and are being developed to improve continuous self-monitoring, increasing 
subject efficacy in diabetes management during normal daily activities. [12, 60] 
One of the first commercial wearable devices to continuous monitoring blood glucose was 
GlucoWatch® providing glucose readings every 20 min during 12 hours through the skin via 
reverse iontophoresis [61]. In 2007 it was discontinued due to skin burning effect. Besides the 
technology used in this device several more non-invasive techniques have been developed along 
these years: Bioimpedance spectroscopy, a non-viable technique to continuous monitoring, 
requiring 60 minutes of rest before BG measuring; Electromagnetic sensing, with the 
disadvantage of being strongly affected by the temperature [62]; Fluorescence technology that 
includes an implantable fluorescence-hydrogel sensor and a wearable photo detector to 
monitoring continuous BG [60]; Mid and near infrared spectroscopy are both possible 
technologies, but presents several barriers, like weak penetration and reading correlation 
respectively; Measurement of BG through the eye is also being developed through ocular glucose 
sensor, technology already used by Google to developed a prototype that has been recently 
taken to the FDA for early independent clinical trials [12]; Ultrasound can also be used, 
providing high sensitivity but with some interference due to biological compounds [62].  
These technologies have been already used in the development of several non-invasive BG 
wearable monitoring devices, like EyeSense and SCOUT. In some of these devices there are also 
temperature sensors, skin perspiration sensors and actigraphy sensors to predict energy 
expenditure, helping in the insulin administration needed.  There are still several challenges and 
barriers in this area, leading to a constant effort from many research groups to develop new 
technologies and methods to get a stable, reliable, conveniently and economic continuous 
monitoring wearable device. [61-63] 
Very recently Dexcom, Inc has become the first company to obtain FDA pre-market approval 
for their mobile application to support continuous monitoring. This application can display data 
from their G4 Platinum CGM System, a system to measure blood glucose from a needle with a 
sensor inserted just under the skin. [64] 
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2.3.7.  Skin Perspiration 
Skin perspiration is not a clinical parameter but a physiological sign very used to analyze the 
human reaction to several situations. Depending of the subject, certain life situations will cause a 
reaction from the autonomic nervous system (ANS) that can stimulate an increase of skin 
sweating. This moisture will change the electrical conductance of the skin, allowing measuring 
the quantity of sweat produced by sweat glands, named as galvanic skin response (GSR). As ANS 
is responsible to control other physiological parameters like heart rate, respiration and blood 
pressure, GSR has been used alongside the acquisitions of some of these signals. For example, 
skin perspiration and heart rate variability can be used to classify mental states, helping in the 
distinction, as also in the detection of mental stress. [65, 66] 
In sports, skin perspiration continuous monitoring is considered an important physiologic 
sign with enormous applications in this area and human behavior, opening a new field of 
research in the clinical settings, such as in dehydration area. A study presented in the literature 
showed that skin perspiration cannot be interpreted correctly without knowing the physical 
activity context. [4, 66] 
From perspiration it is possible to obtained information about the physiological condition of 
the subject due to the several ions and molecules that constitutes it. For this reason it is 
considered an excellent biofluid for non-invasive chemical sense. This able the identification of 
pathological disorders through sweat through ions levels like: sodium, ammonium, calcium and 
lactate levels which are indicators of electrolyte imbalance but also of cystic fibrosis, 
osteoporosis, bone mineral loss and physical stress. As already referred, physical stress is an 
important factor, indicating in real-time a feedback about stress levels and is also used in the 
psycho-physiological evaluation of militaries undergoing intense training. Taking in account 
these possible molecules levels indication, skin perspiration would be a benefit in clinical 
environment. [4, 13] 
Regarding the technology used to monitoring skin sweat, there are two main types of 
sensors: Epidermal-based sensors which have a conformal contact between the electrodes 
surface and the biofluid like elastomeric stamps to print electrodes directly on human epidermis 
for continuous monitoring; Fabric/flexible plastic-based sensors are the most used and have a 
main advantage of constant contact with a large surface area of the skin. These last sensors can 
be embedded in the fabric or screen-printed into it and their technology can be based on 
conductometry or potentiometry to obtain specifics measurements like pH, NH4+, K+ and Cl- [13]. 
Jeehoon Kim et al. [65] have recently presented a new sensor to continuous measure GSR with 
high wearability and usability in a wide variety of fabrics. This feasible sensor is small, flexible 
and the surface is made of a dry polymer foam electrode with the aim to maintain a stable 
contact with the human body. 
A new technology to continuous skin perspiration monitoring has been developed by 
Gengchen Liu et al. [67] based in microfluidic conductivity. Sweat passes through a microfluidic 
channel, where the application of a voltage results in the solution ionization. The resistance 
across this channel is measured obtaining the corresponding sodium concentration. There are 
still several problems related to the introduction of sweat in the channel, but according to the 
authors, this technology, with a microcontroller and a Bluetooth module, can have the ability to 
be used as a wearable continuous skin perspiration monitor. 
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2.3.8.  Capnography 
Blood oxygen saturation measurement by pulse oximetry is a widely used method to access 
arterial oxygenation, but is not the best of the technologies. A better one is capnography, a non-
invasive method and cost effective to avoid clinical complications that is becoming an important 
parameter in patient safety. [37, 68] 
Capnography continuously measures the inhaled and exhaled concentration of carbon 
dioxide (CO2) in the respiratory gases, calculating the CO2 partial pressure in the arterial blood. 
This measurement is made through air capturing just below the nose, where then it goes to 
capnography device to perform a CO2 quantification. Capnography sign has a characteristic 
waveform from which is possible to obtain the respiration rate (Figure 2.3.4). It is possible to 
visualize changes in CO2 concentration and its maximum, as also the speed of expiration. The 
technology to CO2 measurement is based on infrared, and an effort has being made to decrease 
response time and increase this technology accuracy. [69] 
For more than 25 years, capnography has a widely use in clinical practice as integral part of 
anesthesia care in operating rooms. This allows the anesthesiologists to evaluate the 
consciousness level of the patient during the sedation process. When the patients are 
transported to the intensive care unit (ICU), they are not continuous monitored with 
capnography due to its absence, a problem that the American Heart Association has already 
reported, recommending the use of capnography also outside the operating rooms. Recent 
studies referred in the literature showed a high correlation of morbidity and mortality with the 
underuse of capnography in ICUs. [68] 
 
Figure 2.3.4- Capnography waveform illustration, composed by a periodic sign that reflects the CO 2 
partial pressure during a respiratory cycle. A – during a normal respiratory cycle CO2 partial pressure 
varies according to the illustration and is divided in four phases: I, II, III and 0 that correspond to the 
inspiration. Just before this action, a maximum pressure of CO 2 is verified, nominated as end-tindal PCO2 
(PETCO2). Arterial PCO2 is always higher than the higher level of PCO2 measure due to the alveoloar 
dead space.  B – Capnography volume different components which are correlated to the expired volume 
of air. C – An example of a recorded time capnogram during cesarean delivery general anesthesia (phase 
IV corresponds to PETCO2). Adapted from [68]. 
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Several reasons have been enumerated by Bhavani Shankar [68] from Harvard Medical 
School, to explain why capnography should be considered a routine monitor, such as the fact 
that this method can be used as a guide to metabolic rate, or as an essential adjunct to monitor 
the integrity of airway, cardiac output and ventilation.  
Capnography is becoming a prevalent vital sign on portable devices and is helping first 
responders make life-saving decisions, and also in sleep apnea diagnose and monitoring. Sleep 
apnea is where capnography is mainly used outside the clinical environment. Normally sleep 
apnea syndrome is diagnosed and monitored using polysomnography or cardio-respiratory 
polygraphy, both high costs methods and dependent on the access to a specialized sleep 
laboratory. An investigation published in 2005 by Rainer Dziewas et al. [70] showed that 
capnography by its own, can make an early diagnose of sleep apnea syndrome, facilitating 
patients in the diagnose obtainment. Nowadays, this technique is being used to monitor subject 
with sleep apnea. A continuous monitoring is possible due to portable and wearable devices like 
MediByte from Braebon Medical Company that can be used at home with only 10% of a sleep 
laboratory usage cost. [71]  
In a near future it is expected that capnography become widely used outside clinical 
environments. To ensure this, manufactures should make an effort to produce reliable, cost 
effective and portable capnography units with quick calibration procedures. [68] 
2.3.9.  Body Temperature 
Body temperature represents the balance between heat produced and heat lost, known as 
thermoregulation, and it can be affected by several factors, such as underlying pathophysiology, 
skin exposure and age. Body temperature deviations from normal are an indication of ill health, 
and an higher deviation represents a more severe health problem. Body temperature can be 
divided in two types: surface body temperature and core body temperature. In medical practice 
it is important to measure both of these values, in several body sites, as a recommendation of 
best practice. Skin temperature can be easily measured, using, for example, an optical infrared 
thermometer, and can be used in sport activities, joined with heart rate sensors, to monitor 
exercise intensity. On the other hand, core temperature is more important, indicating well-being 
and health condition of humans, but it is also more difficult to acquire. [14, 38, 72] 
Several methods can be used to measure body core temperature in different places, such as 
through tympanic, oral and rectal measurements, but also in temporal and pulmonary artery. 
These places are not very feasible to be used in continuous monitoring, so new methods are in 
development. For example, Kumar Saurabh et al. [73] developed a body core temperature 
estimation method, using two heat flow channels with different thermal resistances. Using a 
simulation model they can estimate body core temperature, but further research is needed to 
enable an accurate result. 
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2.3.10.  Other physiological parameters 
2.3.10.1.  Motion Evaluation 
The evaluation of the human body movements has several applications in medical 
rehabilitation and posture evaluation. Beside these applications, motion evaluation is strongly 
used in actigraphy, a monitoring method to evaluate human rest and activity cycles, providing an 
insight of daily activities routine. [3, 12, 69] 
In medical rehabilitation it is important to monitor mobility, in specific therapeutic exercises 
to evaluate movements and help in exercise techniques improvement, maximizing patient 
recover. A WHD, with the proper sensors, can provide guidance and feedback to the patient and, 
if needed, generate warnings based on the patient physiological conditions. Pulmonary 
rehabilitation can be also included in this type of monitoring, helping patient to complete a 
physical activity rehabilitation program. Muscle activity can be recorded and associated to 
motor functional tasks, as also muscle stimulation. Motion evaluation and muscle activity can be 
used in sport activities to assess physiological signals and body kinematics during exercise 
leading to athlete performance improvement. Posture is also an important factor that as a 
particular interest in patients submitted to hip surgery. [3, 12, 69] 
To measure body movements, several sensors are embedded in textile WHD or in the 
portable units, like in the portable unit of Vital Jacket®. These sensors can be accelerometers, 
magnetometers, gyroscopes, electromyography electrodes and even stimulators. To obtain 
distance data, a GPS can be also added to the device. Complex body movement patterns can be 
measured, combining these sensors along with WHDs fabric, assessing to a higher amount of 
human body movements.  
2.3.10.2.  Cardiac Devices 
The increase of implantable cardiac devices is leading to a development of long-terms 
surveillance, to improve patient safety and care. These devices are mainly implantable 
pacemakers, cardioverter defibrillators and cardiac resynchronization therapy systems. A 
remote monitoring of these devices will minimize the need of caregivers in several situations, 
allowing an early detection of adverse events and prompt corrective measure, also accessing to 
up-to-date information stored in the devices memory. The incorporation of new communication 
technologies will provide a daily, remote, wireless, patient independent ambulatory monitoring 
of medical and technical data. A study, in a large population sample with this type of system, was 
followed during four years, concluding that, if the system was intelligently used, it was capable 
to improve care and increase safety of these patients. [74] 
 
 
 Wearable Sensing of Physiological and Ambiance Parameters 
33 
 
2.3.10.3.  Stroke Volume 
According to Thomas Ahrens [37] stroke volume (SV) should be a vital sign to measure in 
patients monitoring. United Kington and United States encouraged clinicians to start to use 
technologies like flow Doppler to measure SV. This allows measuring the blood volume that is 
pumped from a ventricle of the heart during each beat, helping in a faster evaluation of the heart 
function. This is a clinical used technique which has not been implemented in wearable devices 
due to its specificity. [69] 
2.3.10.4.  Pain, Level of consciousness and Urine Output 
These three parameters are proposed by Malcolm Elliot and Alysia Coventry, in the literature 
[38], as additional signals to identify patients who are clinically deteriorating. According to the 
authors, pain should be considered one of the most reliable indicators to ensure that 
management methods in the clinical environments are appropriate and effective. The level of 
consciousness is defended has a measure that can be assed using a common neurological scale, 
named Glasglow Coma Scale, with no need of neurological sign assessment. Urine output 
evaluation is also recommended, but this monitoring is only made in a clinical environment to ill 
patients. Although these three signals are very important in patients’ medical care, they do not 
require continuous monitoring that justifies the implementation of such parameters evaluation 
using a wearable device. 
2.3.11.  Ambiance Parameters Measurement 
Ambiance parameters have a high relevance in several human body monitoring areas. The 
most used sensors are temperature, ambient light, humidity and sound level. The continuous 
monitoring of air pollutants is also important due to its association with cardiac diseases as it 
will be furthered discuss. 
According to the measurements obtained in ambiance sensors it is possible to estimation the 
occupancy activity of subjects, easily estimating metabolic rate, mainly in indoors environments 
due to the non-contribution of external factors. According to a study made by Ming Jin et al. [75] 
it is possible to assume several daily indoor activities through light, temperature and humidity 
measurement patterns. They develop a wearable device with these three sensors and analyzed 
daily routines such as: climbing stairs due to a periodic pattern in the light level; the indoor 
location when their characteristics are known; and rest periods after walking or running due to 
a humidity increase. This study proved that is possible to analyze ambiance features with the 
aim to recognize indoor activities. 
Outdoor daily activities should also be continuously monitored with ambiance sensors to 
analyze ambiance characteristics that the human body is subjected during sport activities or 
simply rehabilitation exercises. Temperature and humidity can be important to evaluate 
dehydration [12]. Air pollutants are also considerate an important variable to monitor due to the 
high correlation with cardiac diseases. Like is referred in the literature [76], although little is 
known about the possible mechanism for this correlation, it has been proved that air pollutants 
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have a strong association with a high risk of ventricular tachycardia in elderly subjects with 
coronary artery disease. High concentrations of these substances should be medically relevant 
since they can also increase arrhythmia occurrence rate. 
Ambiance parameters such as ambient light, sound and temperature are also important in 
sleep quality and quantity evaluation. For example, a sound sensor joined with an actigraphy 
sensor is an important tool to study sleep disturbances suffered by people living near 
airports.[77] 
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2.4.  Market and Trends Analysis  
This section is going to analyze WHDs market and trends. Combined with the discussion of 
the previous section, it will allow to define the most usable and needed scenarios, both in 
medical and personal use monitoring.  
To perform a complete market analysis of WHDs, it is necessary to understand in what part of 
the market these type of devices are included and then follow market lines, to analyze specific 
markets. This approach will allow us to understand market values and trends in near areas, 
which can also be possible target areas in a near future. 
Wearable devices are estimated to grow at an high rate, with a market value of approximately 
$12,500 million in 2018, which is much higher than the value of 2014 of $5,000 million [78]. 
WHDs are included in this market segment and can be categorized according to classification 
shown in figure 2.4.1. In this figure it is possible to understand that, wearable devices, in general, 
are increasing with a high rate. From 2014 to 2015 it is expected that smart watches increase 
drastically (increase rate ≌ +250%). The use of wearable devices in healthcare (increase rate ≌ 
+55%) and sports/activity trackers (increase rate ≌ +36%) are also expected to increase 
considerably, which is a great prediction for Vital Jacket® since it can be applied in those areas. 
On the other hand, it is important to refer the smart clothing low increase prediction. This fact 
can mean two things: that there is a lack of this type of products in the market, which would be 
the more credible hypothesis, since this is a new area; or can represent a low market demand on 
smart clothes, which is less probable, due to the lower technology of smart clothes available in 
the market.  
 
Figure 2.4.1- Shipments of wearable computing devices worldwide by category from 2013 to 2015 (in 
millions). Adapted from [79]  
Independently of the smart clothes low increase, it is important to retain that main possible 
markets for Vital Jacket® (healthcare and sport/activity trackers) are expected to increase with a 
high rate as already referred. To evaluate these three segments, it is important to know their 
evolution independently and what are their trends in a near future. 
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To better evaluate the market sector of smart clothes, figure 2.4.2 shows a closer look of its 
evolution. In this figure it is possible to observe that, this year, a duplication of shipments is 
expected comparing to last year, 2014. Despite the low number of shipments in relation to the 
other segments, smart clothes market is increasing and fast, regarding that in 2013 this segment 
was almost inexistent. 
 
Figure 2.4.2- Shipments of smart clothing/fabrics worldwide from 2013 to 2015 (in millions). 
Adapted from [80]. 
Sport/activities trackers segment can be divided in several areas like it is shown in figure 
2.4.3. The study made to get this data and trends included different types of devices, such as 
heart rate monitors, connected weighing scales, smart sports clothing, activity trackers and high 
end sports watches. The evaluation of the results obtained conclude that “mHealth 
Wellness/Sports & Fitness device market” is expected to grow to $3.8 billion in 2020, mainly due 
to activities trackers  and smart watches in general [81]. It is important to refer that smart 
sports clothing area is expected to increase, in fact, considerably in relation to present year. This 
trend information alerts us to a main increment for activity trackers in the near future, detail 
that should be taken in consideration for WHDs development in this segment.  
 
Figure 2.4.3- mHealth Wellness/Sports & Fitness Device Market  (in millions). The orange color is 
referred to connected weighing scales. Adapted from [81]. 
 Market and Trends Analysis 
37 
 
To evaluate healthcare segment trends two approaches are made: one related to wearable 
medical equipment; and other concerning home healthcare monitoring devices. In this last one, 
market trends are presented in figure 2.4.4. This study was mainly based on the following home 
monitoring devices: diabetes care devices, blood pressure monitors, multi-parameter patient 
monitoring, apnea and sleep monitors, holter monitors and heart rate meters. From the market 
trends in figure 2.4.4, it is possible to conclude that in next three years, home monitoring devices 
will duplicate compared to 2014. The increase of home monitoring is a great contribution to 
predict a growth of WHDs in healthcare.  
 
Figure 2.4.4- Connected home medical monitoring devices (in million). Adapted from [82]. 
Regarding wearable medical equipment, a study about China market is presented as an 
example to evaluate wearable medical equipment trends (Figure 2.4.5). In this approach, it is 
possible to see that the higher increase will not be from 2014 to 2015, but from 2015 to 2016, 
where a higher growth rate is observed. This trend is very favorable in Vital Jacket® sales 
estimation, but should also be taken in account to prepare this WHD for a possible increase of 
competitors, in its market, for the next years. 
 
Figure 2.4.5- Growth rate of China wearable mobile medical equipment market from 2012 to 2017. 
Adapted from [83]. 
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Healthcare ambulatory monitoring segment can be divided in several areas. A recent study by 
IHS Inc. [84], expects that mobile telehealth solutions are going to become the standard in 
remote patient monitoring. This study refers trends for 2014 according to a 2013 telehealth 
market and divides it in five main areas: congestive heart failures (CHF); chronic obstructive 
pulmonary disease (COPD); diabetes; hypertension; and mental Health. Figure 4.1.6 represents 
the distribution of each of these areas on the market. 
 
Figure 2.4.6- The World Market for Telehealth – Patient by Conditions. This is a patient distribution 
made for 2014 with a total number of patients of 725 thousand. Adapted from [84]. 
Sleep apnea, as already referred in the previous section, affects worldwide population, with 
an estimation of 40 million people only in the USA. To evaluate this market area trends, IHS Inc. 
made a research from where it can be concluded that ambulatory/home portable sleep devices 
presents the highest growth market in sleep diagnostic devices segment. It is also important to 
refer that it was projected that global home sleep market reach $36.8 million this last year, with 
a growth percentage of 7.1% in relation to 2013.[84] This market trend is presented in figure 
4.1.7, where it is possible to see a constant growth of ambulatory/home portable sleep testing 
devices. 
 
Figure 2.4.7- Ambulatory/Home Portable Sleep Testing Devices (Left axis: Unit Shipments; Right 
axis: Growth percentage). Adapted from [84]. 
To complete this market analysis it is important to mention a fact: mobile health technology 
worldwide market in 2011 was about $1.2 billion and it is expected to reach an amazing $11.8 
billion value in 2018 [85]. This is a valuable estimation is also related to Vital Jacket® since it is 
prepared for mobile technology with Bluetooth technology.  
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2.5.  Challenges and Future Perspectives  
Wearable health devices are a recent area in healthcare and still under development with the 
aim to be integrate in the medical health system. There are some personal monitoring devices on 
the market capable to provide instantaneous single-parameter assessment and transmission. 
But, the main purpose of WHDs is to integrate several biosensors, intelligent processing and 
alerts, to support medical applications, while interacting with health providers, using some of 
the technology that is not yet available on the market, only in research. The existing devices are 
highly expensive and work wireless based, technology that is not available everywhere in many 
countries, such as France where many consumers do not have access to broadband internet as 
reported in the literature in 2012. This type of data communication leads to another problem: 
privacy. This is a problem that concern healthcare, in the prevention of information, leading 
people to have lower confidence in these devices, resulting in ethical problems. This is one of the 
main barriers and the suggested solution is to create clear guidelines to providing privacy, 
confidentiality and proper use of electronic medical information. All this effort will have an 
impact on societies, such as in China where WHDs may contribute to lower healthcare cost by 
introducing preventive healthcare strategies, cutting equipment and labor costs, eliminating 
unnecessary health services. [4] 
The next few years present a set of new interesting challenges in WHDs and, to overtake 
them, an adaption of these technologies should be made, studying user requirements to develop 
an integrated approach in health and wellness services, instead of devices and applications for a 
single disease. To develop such devices and integrate them in an architecture of intelligent home 
services some main issues must have a special attention, such as: device efficiency, reliability 
and unobtrusiveness; privacy and ethical issues as already covered; legislation within and 
between states or countries; interoperability; end-user training to use WHDs; and social 
inclusion preventing users isolation, which can lead to a decrease of interaction with caregivers 
and physicians. [4, 16]  
In the sensor technology area, there are three main aspects with particular attention: long-
term stability; resiliency; and biocompatibility. In textile-based sensors, washes can cause 
mechanical, chemical and heat degradation, so an effort must be made to develop more resistant 
sensors to overcome stress caused by extended periods of use. Smaller sensors are also another 
important requirement, being associated to the electronics development, to increase 
functionality and portability of WHDs. The sensitivity of wearable sensors should be also 
analyzed, and a possible improvement includes the use of nanomaterial-based signal 
amplification. Biocompatibility must be highly considerate, covering sensors with antimicrobial 
or protective coating, preventing any potential toxicity of nanomaterials. [13] 
Wearable health devices are able to monitor any vital sign of human body, from advance 
sensor supervision in the case of infant respiratory to soldiers on the battlefield or even in 
fitness applications. This particularity of WHDs creates a big excitement around this technology 
and many opportunities to continue its development. With new advances in new materials, 
electronics and telecommunication information technology, together with the entry of big 
multinational companies, such as Google and also smaller companies, like NovioSense, WHDs are 
expected to overcome their challenges and enter in the consumer market with a higher impact in 
the next few years. [4, 11, 13] 
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  Chapter 3
VitalLogger: An adaptable Wearable 
Health Device 
italLogger is a wearable health device that was developed for the first time in this Master 
Thesis. This device extends VitalJacket® main board, adapting it to be capable to acquire a 
higher amount of signals. VitalLogger device acquires and synchronizes signals mainly 
related to the human body but also with some ambiance conditions that can contribute to 
different physiological behaviors.  
To analyze which are the most wanted sets of vital and ambiance variables to be monitored 
nowadays and the most needed ambulatory sensors, it was made a selection of the most 
important monitoring scenarios and the most needed sensors, based on the study performed in 
the previous Chapter. After Biodevices, S.A. analysis of these scenarios, a decision was made in 
order to develop a prototype that, joined with their technology, was able to offer a higher 
number of vital signs acquired, taking the first steps in VitalLogger design. 
In this chapter the subjects referred above will be detailed and the development of the new 
prototype will be explained, such as all the steps, decisions and implementations made to get to 
the final prototype. A suggestion for the implementation of the developed prototype as a 
possible product will also be presented. 
 
 
V 
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3.1.  System Architecture 
VitalLogger has the main objective to aggregate a specific set of sensors, according to the 
desired scenario, acquiring the maximum vital and ambiance data from the human body, leading 
to a better diagnostic in medical cases, or just to be used as a personal monitoring device. In the 
following picture (Figure 3.1.1) it is possible to see a components diagram where VitalLogger is 
inserted.  
  
Figure 3.1.1 – Component Architecture where Vita lLogger is inserted. ViltalX is the Android platform 
were all the sensors data are collected, including VitalLogger device. 
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On the top of the image is the Android aggregator component which was named “VitalX” with 
the logotype presented in its left side. This is where all the information from several devices is 
gathered, stored and showed to the user. This Android application is being developed by another 
Msc. Student in his Master Thesis project and has the main goal to give the possibility to the user 
to choose which sensors he wants to acquire. These sensors can be from the Smartphone itself 
(e.g. gyroscope or light sensor), or can be from an external device that is connected. In this case 
it can be from VitalResponder2 (a monitoring unit to help first responder get access to ambiance 
conditions to make important decisions), some external module wanted by the user and, the 
most important device in this Master Thesis, VitalLogger. As it can be seen in the component 
architecture image, VitalLogger device is mainly divided in two parts: its firmware and its 
sensors. In the first one, a division is made between the high level firmware and the low level 
firmware. The high level firmware consists in the communication implementation to transmit 
data between the VitalLogger and “VitalX” aggregator, allowing the user to select which sensors 
data he wants to acquire from VitalLogger. This last section is also being developed by another 
Msc. Student as his Master Thesis project. This Master Thesis is inserted in the low level 
firmware development, where all the integrated components (e.g. analog front-ends and 
microcontrollers) are programmed, and in the sensor module of VitalLogger.  
This Master Thesis objective is to propose a possible extension of the number of sensors in 
Biodevices, S.A. technology, extending VitalJacket® device in order to design VitalLogger 
prototype. This work consists in the implementation of new sensors in Biodevices, S.A. 
technology such as the development of their low level firmware and calibration. With these 
three steps it is possible to obtain a viable prototype with a possible use as a wearable 
technology. 
The contribution of this Master Thesis joint with the other two Msc. Students work, are the 
first steps in the creation of a user configurable and adaptable system, allowing to monitoring 
the desired signals, according to the devices connected to a smartphone. 
In order to choose which set of sensors would be implemented, a deep analysis of wearable 
devices was presented in the second Chapter, giving information about the most used sensors in 
these devices, what are the most needed vital signs to be monitored in ambulatory cases and the 
future of wearable devices in the market, in both medical and health perspectives. Gathering all 
this information it was possible to create a set of sensors for the some important scenarios, such 
as cardiology scenario or sport scenario for example. The next topic will refer these scenarios 
and their set of sensors according to the information in the second Chapter. 
3.2.  Monitoring Scenarios  
This topic presents a set of sensors for several scenarios selected according to the 
information in the second Chapter. After the description of the sets of sensors and the scenarios, 
cost estimation for each scenario is also presented due to its high relevance in economic 
decisions. These two approaches joined with the market trends analysis were presented to 
Biodevices S.A, leading to a decision of a specific prototype development. 
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3.2.1.  Description 
Gathering the research made in wearable health devices, wearable sensors, medical and 
personal ambulatory monitoring requirements and with market and trends analysis, it was 
possible to select the most important monitoring scenarios and define the setup of sensors for 
each one. These scenarios can be divided in four big monitoring groups: Sports&Activity 
Monitoring; Cardiovascular Monitoring; Sleep Monitoring; and Diabetes Monitoring. A fifth 
scenario was designed, named Multi-Parameter Monitoring (Figure 3.2.1). This last scenario is 
based on the most essential monitoring sensors in a clinical environment to evaluate human 
health, according to the research made and to the five most important vital signs referred in 
Chapter 2, section 3. 
 
 
Figure 3.2.1 - Wearable health devices ambulatory monitoring scenarios, with the respective wearable 
sensors setup, according to each scenario needs.  
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3.2.2.  Associated Costs 
To better support Biodevices, S.A. decision an effective cost approach was made, analyzing 
and researching about the costs associated to each scenario, according to each set of sensors.  To 
perform this cost estimation, first, it was made an individual approach in the sensors used to 
acquire each parameter, analyzing different ways to be implemented and sensors variations in 
the measure of same physiological sign using different technologies. Table II presents for each 
physiological/ambiance variable the maximum and the minimum possible public cost for one 
unit, regarding their acquisition, as also the several types of technologies and possibilities that 
were considered in this approach. 
Table II- List off all the Physiological/ Ambiance Variables needed to be implemented to complete all 
the setups of sensor from each scenario. For each sensor it is made a public cost estimation based on the 
referred approaches made for each sensor, regarding its technology and way to wear or use.  
Physiological/ Ambiance 
Variables 
Cost Range 
estimation (€) 
Approaches take in account for  
cost range estimation 
Oxygen Saturation ≈ 15 - 125 
 
-Analog and Digital Finger Sensors; 
-Analog Ear Sensors; 
-Analog Sensor for both Finger and Ear; 
-Digital Finger Sensors with Bluetooth. 
 
Skin perspiration ≈ 15-280 
 
-Digital and Analog Sensors. 
 
Respiration Rate ≈ 7-68 
 
-Digital and Analog Sensors based on 
chest belts or in wearable fabrics; 
-Analog Sensors based on the airflow in 
the mouth and nose; 
-Analog Sensor based on the flexibility. 
 
Blood Pressure ≈ 12-240 
 
-Digital Sensors based on an arm band to 
be used on the arm and on the wrist, 
with and without Bluetooth. 
 
Blood Glucose ≈ 27-40 
 
-Digital Sensors based on the reading of a 
small blood sample in a strip, with and 
without Bluetooth. 
 
Capnography ≈ 350-1830 
 
-Analog Sensors to measure the CO2 
concentration in the airflow of user 
mouth or nose, with or without using an 
airway adapter (intubation). 
 
Light sensor ≈ 4-5 
 
-Digital sensors by their own to be 
implemented and already in pre-
fabricated digital modules. 
 
Sound Sensor ≈ 2-13 
 
-Digital sensors by their own to be 
implemented and already in pre-
fabricated digital modules. 
 
Ambiance Temperature 
and Relative Humidity 
≈ 7-10 
 
-Digital sensors by their own to be 
implemented and already in pre-
fabricated digital modules. 
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It is important to refer that the main influence of cost value variation is due to the fact of the 
most expensive analog or digital sensor being sold already with electrical components 
developed and some of them also with medical certifications. For this case of study both analog 
and digital sensors were considered, but the main interests for this Master Thesis were the 
analog sensors to allow a unique electronic implementation and adaptability to Biodevices, S.A. 
technology. 
After this, cost estimation was made for each scenario, according to the sensors that make 
part of each scenario to obtain the defined set. Table III shows the public cost of each scenario 
according to the set of sensors chosen, representing the minimum and maximum costs based on 
the previous table. This table also refers the number of sensors needed to be added to complete 
the set of each scenario. 
Table III- Public cost estimation for each setup of sensor of the presented scenarios. This estimation is based on the 
values presented in the individual sensor cost estimation. 
Scenario Minimum Cost (€) Maximum Cost  (€) 
Number of sensors 
to be added 
Sports&Activity Monitoring ≈ 45 ≈ 1100 4 
Cardiovascular Monitoring ≈ 40 ≈ 650 3 
Sleep Monitoring ≈ 380 ≈ 2770 5 
Diabetes Monitoring ≈ 55 ≈ 325 2 
Multi-Parameter Monitoring ≈ 34 ≈ 1055 3 
3.2.3.  Biodevices, S.A. Development Decision  
Although Biodevices, S.A. recognized these scenarios and their setup of sensors very relevant 
and with a high market impact, due to the restrict time of Master Thesis work and the 
complexity to implement a new sensor in their technology, none of these scenarios were chosen 
to be implemented. Instead of the implementation of a complete set of sensors from one 
scenario, a main sensor was chosen to be the main focus of this work. This sensor was the 
Oxygen Saturation Sensor to obtain an accurate value of the oxygen saturation percentage from 
user or patient blood. Ambiance Temperature and Relative Humidity variables where also 
chosen be acquired using a sensor, as also Gyroscope sensor to acquire actigraphy data. 
The following topics of this chapter will be focus on the development of a prototype that 
extends Biodevices, S.A. to acquire Oxygen Saturation data, ambiance temperature and relative 
humidity, and also gyroscope data. It is important to refer that this prototype will extend the 
existing technology, so, beyond the new data that will be acquired, already implemented sensors 
will also be acquired, such as ECG, hear rate and Accelerometer. The prototype development 
topics will be divided in the hardware development, firmware development and calibration and 
validation of the new sensors implemented. 
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3.3.  Hardware Development 
To develop the prototype hardware new theoretical concepts were acquired and new areas 
were covered. Communication protocols master-slave were studied, namely Serial Port Interface 
(SPI) which was the protocol chosen to be used in this prototype; microelectronic fundamentals 
related to microcontrollers and analog to digital converters, also known as Analog Front-Ends 
(AFEs); and mainly related to the design of Printed Circuits Boards (PCB’s) and all the process to 
make a PCB production. To design all the electronic schematics and PCB prototype development 
it was used a PCB design software.  
After this study, a research was made to choose the best components to acquire the signals 
that were chosen by Biodevices, S.A., mainly the oxygen saturation which is the main focus of 
this prototype, as also the most complex. To read oxygen saturation it was chosen, joined with 
the company, an AFE named AFE4400. Developed by Texas Instrument, this fully-integrated AFE 
belongs to the first family of AFEs specially designed for pulse oximetry and presents a high 
reliability and configurability. This AFE controls the LEDs transmission and detection sections, 
converting analog readings into a digital output according to SPI protocol. The connection 
between the prototype and an Oxygen Saturation sensor was decided to be made through a DB9 
connector because it is one of leading connectors in medical devices of this type. To get 
ambiance temperature and relative humidity it was selected the HIH6130 digital sensor due to 
its ability to output a combination of these to variables in a digital format (SPI in this case). As a 
gyroscope sensor, it was chosen the LSM330DLC produced by STMicroelectronics, mainly due to 
its SPI communication possible configuration.  
 
The main idea for the hardware structure was to produce a hardware board that could be 
able to connect to Biodevices S.A board (main board) through the same connector as the Vital 
Jacket® T-shirt connector, enabling the use of Biodevices S.A board microcontroller and 
extending their technology to evolve it into the VitalLogger device. To get this specification it 
was made an electronic prototype board where Vital Jacket® T-shirt connects in one side and, in 
the other side, a flat cable to connect with Biodevices, S.A. board. This design allows the 
prototype board to function as a bridge, where the acquired signals from the prototype are sent 
to the main board joined with the signals from Vital Jacket® T-shirt. Figure 3.3.1 shows a 
component diagram representing the interaction between VitalLogger prototype modules.  
 
Figure 3.3.1-Component diagram of VitalLogger prototype. 
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The hardware development of this Master Thesis is based on the prototype board (extension 
board) development, extending the main board to acquire a higher number of physiological and 
ambiance variables. 
The following topics will focus in the schematics of the electronic circuits made for each 
component of the extension board and in the PCB design this board.  
3.3.1.  Electronic Circuits Schematics 
The schematics for the development of this prototype were divided in 6 main groups: Vital 
Jacket® connector, temperature and relative humidity sensor, AFE4400 module and DB9 
connector, gyroscope sensor, power management module and the connector to the main Board 
of Biodevices, S.A., like it is presented in Figure 3.3.2.  
 
Figure 3.3.2- Schematic representation of the developed prototype hardware architecture, 
representing each developed module and their SPI communication interaction.  
The image presented above is a schematic representation of the overall circuit that was 
developed, being the added modules connected to the existing channels in order to interact with 
the microcontroller from the main board.  
To better understand the connections between the developed schematic modules it is 
important to explain SPI communication protocol fundamentals. SPI protocol is a 
communication protocol between one master and one or more slaves. A Slave Select (SS) 
channel allows to select which slave is going to communicate with the master and must be an 
individual channel for each slave. It is important to refer that a slave is active when it slave select 
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signal is low. In Figure 3.3.2 only the AFE4400 slave module has a slave select channel because 
the connector on the main board only has one. For the two remaining slaves modules it was 
made an external connection. Besides slave select channel, there are three more channels that 
are common to all slaves, communicating only with the slave that is active by the slave select 
channel. These three channels are the Serial Clock (SCLK) channel, the Master Output/Slave 
Input (MOSI) channel and the Master Input/Slave Output (MISO) channel. Serial clock is the 
communication pacemaker, when it goes high or low, depending of the microcontroller 
configuration, a bit is transferred to the slave. MISO and MOSI channels is where the information 
flows between master and slave, being the MOSI channel responsible for the information that 
goes from master to slave and in the MISO channel happens the opposite process, the 
information goes from slave to master.  
In the following sub-topics each of these modules are going to be described and deeply 
discuss to  explain all the details and decisions made. The SPI communications of each one will 
also be explained, but just in the firmware section of this Chapter. 
3.3.1.1.  Blood Oxygen Saturation Module 
This module represents the schematic module of AFE4400 and DB9 connector, the main 
module of the developed prototype, being responsible to acquire pulse oximetry signal.  
Analog front-end AFE4400 is developed by Texas Instruments, specifically design for pulse 
oximetry, having four main routes: clock route, Transmit Route (TX), Receive Route (RX) and SPI 
route communication. Both TX and RX have two routes, a cathode route and an anode route to 
connect to the oxygen oximeter sensor LED and photodiode respectively. To understand how all 
these sections work and inter-interacts, a study and analyses was made for a better 
comprehension of this AFE system. Here is going to be presented a small resume of how this 
system works to understand its complexity and functionality.  
The main characteristic of this system are the timings when the each action occur. These 
timings are programmable in AFE initialization and can be changed, having all a common 
reference timing that is also programmable. This reference is directly correlated to an external 
clock of 8MHz in the clock route. The crystal oscillation when acquired by AFE4400 is converted 
in a 4MHz frequency and is used as AFE pacemaker. 
The main idea how this system works relies on a cycle where the AFE turns on the LED in the 
external oximeter sensor using the TX route and then it turns off and samples the received 
intensity in the sensor photodiode using the RX route to convert this analog input into a digital 
signal using an analog-to-digital converter (ADC). This cycles is made two times because the 
oxygen saturation level determination requires the sample of two light wavelengths, a red and 
an infra-red, as it will be furthered discussed in Section 3.4.2. Two extra cycles are made to 
acquire ambient light and obtain a more accurate result. To better understand when these 4 
cycles occur, it is possible to see in the Figure 3.3.3 the timings when each step of each cycle 
begins and ends.  
It is important to refer that during one sampling process several measurements are made and 
the digital output of the ADC conversion is a mean of those values. The number of values 
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sampled is programmable and in the design of this prototype it will be used 3 samples. When a 
complete reading cycle is made and the digital data output is ready to be read, the ADC ready pin 
(ADC_RDY) gets high for a short instant and then turns low. One of the characteristics of this AFE 
is the capability to subtract the ambient sample to the correspondent LED value. This operation 
happens in the last ADC conversion, being also possible to be read in the SPI output. 
 
Figure 3.3.3- Sampling cycles of AFE4400. This images shows two complete cycles of acquisition and 
ADC conversion [86]. 
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To design an initial working prototype, the electronic circuit was adapted from Texas 
Instruments recommended circuit for a typical application of this analog front-end. Some 
changes were made, such as: some unused resistors were removed; extra digital communication 
ports that were not going to be used in the SPI communication. In this case it is important to 
refer that ADC_RDY was initially used in the initial tests of the prototype, but then, due to its 
non-interaction and influence in the output data acquisition was disconnected. The following 
image (Figure 3.3.4) shows the final schematic with all the changes performed. 
 
Figure 3.3.4- AFE4400 adapted schematic implemented in VitalLogger prototype [86]. 
Texas Instrument gives the advice to isolate the RX route, avoiding external electrical 
interferences. This fact can be observed in the wire of pin 4 (VCM), which was also designed in 
the hardware. Another important part of this electronic is its power supply which needs to be 
according to the AFE4400 power supply requirements. 
3.3.1.2.  Power Management Module 
This module was specifically made to manage the power supply needed for AFE4400. Since 
power supply from main board was 3.3V and Texas Instrument already presents an electronic 
circuit to convert 3.3V in the voltage required for this AFE, the proposed circuit was adapted and 
designed to be implemented in VitalLogger prototype (Figure 3.3.5).  
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Figure 3.3.5- AFE4400 power management adapted schematic implemented in VitalLogger prototype 
[87]. 
AFE4400 has three main voltage requirements: one for RX route (2.0V – 3.6V), another for 
the TX route (3.0V – 5.25V) and a third one for the LEDs that can assume a maximum value of 
5.25V and a minimum of 3.0V or a calculated value according to LEDs voltage. In this prototype 
the voltage used in LEDs is the same used in the TX route, simplifying the AFE4400 power 
supply to only two different voltages, RX and TX. This power management was the one advised 
by Texas Instruments and it was implemented to ensure AFE4400 normal behavior at an initial 
prototype phase. After prototype development and testing, it would be important to try to 
reduce the electronic of this power management, reducing significantly the board space 
required, obtaining, in the future, a smaller wearable system. 
3.3.1.3.  Ambiance Temperature and Relative Humidity Module 
The acquisition of ambiance temperature and relative humidity were also proposed by 
Biodevices, S.A. to be implemented in this prototype. The sensor chosen to acquire both of these 
values was the HIH6130 with a SPI configuration. This digital sensor produced by Honeywell, 
outputs the ambiance temperature and relative humidity in a digital format which make it 
possible to be easily read by a microcontroller like the one in the main board. The electronic 
circuit designed was adapted from the recommended by the producer for an SPI configuration 
(Figure 3.3.6).  
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Figure 3.3.6- HIH6130 adapted schematic implemented in VitalLogger prototype [88]. 
This sensor has a maximum accuracy of the relative humidity in a range of 10% to 90% and 
for the temperature a range of 5ºC to 50ºC. It can measure higher and lower values inside its 
operating temperature range (-25ºC to 85ºC) but with lower accuracy. Regarding its resolution, 
it has a 14 bit of ADC resolution, which results in a relative humidity and temperature resolution 
of 0.04% and 0.025ºC, respectively.  
In the Figure 3.3.6, it is possible to observe that the sensor on the schematic has two possible 
models HIH6130 and HIH6131. These two sensors have the same configuration and both can be 
inserted in this schematic. The only difference is that HIH6131 is more expensive due to its extra 
characteristics that allow it to be used in condensing environments, which can be an important 
factor in future applications. 
3.3.1.4.  Gyroscope Module 
To develop the gyroscope module it was used an inertial module produced by ST 
Microelectronics named LSM330DLC. This sensor has the ability to acquire three independent 
acceleration (3D accelerometer) channels and three angular rate channels (3D gyroscope). It 
possibility to communication using SPI protocol and the fact of being possible to obtain 
accelerometer and gyroscope signals separately is a main advantage, allowing it to only extract 
gyroscope information. The electronic circuit represented in the schematic of Figure 3.3.7 was 
adapted from the recommended by the producer, including only the electronic and connections 
needed to acquire gyroscope values using SPI communication protocol.  
Although this sensor was included in the hardware development and its firmware was 
prototyped, it was not implemented in this Master Thesis work due to time restrictions and 
main board PIC unavailable ports. Its SPI communication process will be briefly presented in the 
Firmware section of this Chapter, but it is important to retain that the firmware made was not 
tested.  
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Figure 3.3.7- LSM330DLC adapted schematic implemented in VitalLogger prototype [89]. 
3.3.1.5.  External Connections Modules 
The external connections are the DB9 connector that is inserted in the AFE4400 schematic 
and two more connectors which are electronically equal between them. One of these two 
connectors connects this prototype to Vital Jacket® T-shirt and the other has the same electrical 
configuration, but with a different socket, connecting the prototype to the main board through a 
flat cable. The schematic of these two connections will not be presented due to Biodevices, S.A. 
copyrights. 
3.3.2.  Printed Circuit Board Design  
After design all the electronic schematics needed, the next step was to design the Printed 
Circuit Board (PCB) using the same PCB design software used in the schematic design. Besides 
the schematics, to make a PCB design the footprint of each component is needed, which is the 
design of the pads where the components will connect to the board. Each component has a 
specific footprint with different pads dimensions according to the component dimensions and 
pins component configuration. Besides this, to create a 3D representation of the board, a 3D 
model of each component is needed. In this case, there are internet repositories where a 3D 
model of almost all type of components already exists, being these imported to the project. 
The board size was chosen according to Biodevices, S.A. technology (35x65mm) and was used 
a two layer design. This design allows having two independent circuits designed in the same 
board, a top one and a bottom one, separated with a non-conductor layer. These two layers can 
communicate through “vias”, which are holes in the board with a conductor material, normally 
copper, connecting both of these layers. 
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The first version of VitalLogger extension board prototype is presented in the following 
figure. In Figure 3.3.8 both layers are shown, where the top is represented in the left image and 
the bottom layer in the right image. 
  
Figure 3.3.8- PCB design of VitalLogger extension board first prototype. The left image shows the top 
layer and the right image the bottom layer.  
In each designed layer it was created a ground plan with two main objectives. First, is to 
reduce any external interference with the main components, functioning almost as an electrical 
magnetic protector. The second purpose is to easily connect all the ground pads of the 
components, reducing the number of printed routes needed. These ground plans are 
represented as red (on top layer) and blue (on bottom layer) large areas that are not connected 
directly to the designed printed routes. 
The next image (Figure 3.3.9) shows the 3D model of the first version of VitalLogger 
extension board prototype, where each component is represented in three dimensions.  
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Figure 3.3.9- 3D model of the VitalLogger extension board first prototype. The left image shows the 
top view of the prototype and the right image the bottom view.  
As it can be seen in the previous images, half of the board space is almost only occupied by 
the DB9 connector and the by electronic bellow that is related to the power management 
module. One of the main specifications of wearable health devices is their small size, 
characteristic that was not very well accomplished in this case, knowing that it is missing the 
main board and the battery. To resolve the power management oversize problem, some tests 
must be done after prototype finalization, as it has been already referred regarding the power 
management schematic section, analyzing the possibility to remove it. If these test lead to a 
positive result the next step will be to make a smaller board to connect to the main board or 
even do a small module to be mounted directly in the main board. This last solution is related to 
the size of the BD9 connection, which would have to evolve into a smaller connector. This 
conversion is possible because oxygen saturation sensor only uses five of the nine channels, and 
adapting the sensor cable into a smaller connector with only five channels would reduce an 
amount of space, obtaining a higher portability and wearability. 
3.3.3.  Board Assembly 
The process how to produce a PCB was also learned. This process has two main phases: a 
phase where the files to fabricate the PCB are generated; and the phase where the PCB is 
ordered. The first one consists in the generation of two main files: a Gerber file with all the 
layers design, used for the fabrication; and another Gerber file with all the drills needed to make 
in the PCB fabrication. The next phase is to order the PCB in a PCB’s producer. To obtain the 
exactly PCB as it was designed, it is essential to verify the Gerber design generated by the 
producer, to see if the top and bottom layers are according the design made. This process can 
take some time depending on the producer Gerber generator and normally some changes must 
be done to get a good result. During this process some errors have occurred in the producer 
Gerber generator such as some undesirable unions between two “vias” or between a “via” and a 
route. Another problem was in the ground plans, where some of them were not designed by the 
producer Gerber generator. These problems were resolved by trial and error and some of them 
were not possible to solve, making a route of ground to connect directly to ground pads avowing 
ground plans errors. The plans that were not accepted by the producer can be seen in Figure 
3.3.11 represented by a larger area in a darker green color on the board. 
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Figure 3.3.10- Produced PCB of the first VitalLogger prototype. 
After ordered the production of the prototype PCB, all the components needed were also 
ordered from two distributors due to the unavailable of some components in both distributors. 
When all the components and the PCB were received, the assembly was made. This process 
was learned and improved with some techniques acquired with Biodevices, S.A. personnel. 
Figure 3.3.12 demonstrates one of the three assembled boards, with the designation of each 
module and also with some electronic changes due to schematic design errors that were 
discovered during the firmware development phase. 
 
 
 
 
Figure 3.3.11- The first version of VitalLogger prototype assembled with each module and connector 
label. 
To evaluate AFE4400 power supply, the values of the TX root and RX root supply were 
verified, obtaining values of 5.03V and 3.07V respectively. These are the expected values of the 
power management circuit developed and are inside the considered range for each of these 
roots.  Then, the connection with the main board was made, as it can be seen in the Figure 3.3.13. 
In this image it is possible to see that the Vital Jacket® T-shirt connector is in a vertical position, 
fact that was due to an error in the first schematics design of this first prototype. In the same 
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image it is possible to visualize, above the flat connection, a wire made connection for the slave 
selection channel of the HIH6130 sensor.  
 
Figure 3.3.12-VitalLogger first prototype connected to a main board  through a flat connection.  
In order to correct some of the errors made in the schematics design, a second version of this 
prototype was designed, but not produced. This second prototype with all the modifications is 
presented in the Appendix A, regarding its schematics and PCB design. 
 After the connection of these two boards, a more secure process was used to keep these 
boards together using a rubber band. Figure 3.3.14 shows this more compact module with the 
oxygen saturation sensor plugged. 
 
Figure 3.3.13- VitalLogger first prototype connected to the main board and with the Oxygen 
Saturation sensor plugged in.  
Regarding the oxygen saturation sensor, three sensors were acquired from two different 
places. One was borrowed by Covidian Portugal to be used exclusively for scientific purpose and 
the other two were bought to a distributor in China. The model was the NellcorTM DS100A Adult 
SpO2 Sensor and its LEDs operate at 660nm (Red) and 905nm (Infra-red) wavelengths. 
After the hardware explanation of the development of this prototype, it will be presented in 
the next section how the firmware was developed. In this section will be discuss the firmware 
architecture for each of the developed sensors modules.  
VitalLogger Extension Board 
Main Board 
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3.4.  Firmware Development 
The firmware development was made using Microchip IDE software, namely MPLAB IDE X to 
implement, using C programming language, the firmware for a specific Microchip 
microcontroller, like the one in the main board. This software as a configuration tool that was 
used to automatically generate the code to the initialization and control of the microcontroller 
pins. The remaining code was made from scratch and divided in four files, three of them related 
to each sensor (AFE4400, HIH6130 and LSM330DLC) and a fourth one to calculate oxygen 
saturation using the acquired values from AFE4400. Beside these four files an SPI control file 
was also done to control and configure SPI communication, allowing sending and receiving bits 
from a selected slave. The microcontroller used in this work has an 8-bit architecture allowing to 
send and/or receive SPI data with 8-bit. The Main file of this firmware was also designed, 
containing all the initializations needed when the system is powered and then a while cycle 
containing all the sampling procedures to obtain a final result from each sensor. Figure 3.4.1 
shows a workflow diagram of the Main file to initialize and read samples from sensors. This 
workflow does not include the gyroscope module because it was not implemented, but its 
firmware will be presented in Gyroscope Module Firmware section. 
 
Figure 3.4.1- Workflow diagram representing the main file of the developed firmware.  
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After the initialization process, a reading from the sensor is performed to get the Red and 
Infra-Red wavelength samples. These values are used to verify if the finger is inserted or not in 
the sensor, avoiding invalid measurements. In the finger presence, more acquisitions are made 
until obtain 100 samples. During this process, after each acquisition a verification of the finger is 
made, so, if the finger is removed after obtain 100 samples, the oxygen saturation level is not 
calculated. When the finger is removed or after the oxygen saturation calculation an ambiance 
variables acquisition is performed. 
The oxygen saturation acquisitions needed to calculate its level are one hundred with a 20Hz 
frequency due to two main causes: the first one is due to the microcontroller that is used to 
acquire samples that has some priority tasks which cannot be stopped, being necessary to get 
readings between those tasks which restrict the sampling frequency; the second cause takes in 
account the physiological heart rate. To calculation oxygen saturation it is needed to get a typical 
oxygen saturation curve and with 20Hz of sampling frequency it is possible to obtain the main 
characteristic of this wave, maximum and minimum values, from 30BPM to 240BPM, fact 
experimentally proven. 
Concerning SPI communication in the developed firmware, it is important to explain that the 
communication between the master and slave is in groups of 8-bit due to the microcontroller 
architecture. These groups are named as register and normally they contain some bits or even a 
byte (8 bits) to identify what is the address of the register and then, the remaining bits or bytes 
contains the information related to that specific register. For example, to define some setting in a 
slave it is necessary, first, to send the address of the register that contains the settings wanted 
and then the remaining register with the high or low bits according to the specification needed. 
Components datasheets has a list of specific registers and their description concerning the 
address and the settings that each bit defines. This concept is going to be used along this section. 
The initialization represented in the workflow diagram is shown in the following image 
(Figure 3.4.2), but now acquired during SPI communication between the microcontroller and 
both slaves, the AFE4400 and the HIH6130. The overall SPI communication process of the 
workflow is presented in Figure 3.4.3. 
 
Figure 3.4.2- SPI digital acquisition of the initialization process. First the pins are initialized such as 
the SPI microcontroller module. The HIH6130 initialization occurs when its slave select ( “SS_T&H”) goes 
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down, which is a very quick process. Just after that the AFE4400 slave select ( “SS_AFE4400”) goes active 
to start AFE4400 initialization process that will be discuss in the following topic.  
 
 
Figure 3.4.3- SPI digital acquisition of the first cycle including the initialization. First it is visible a 
higher density of SPI communication which represents the initialization referred above. Then a reading 
until 100 samples it’s made. The following space without communic ation corresponds to the time where 
the oxygen saturation value is computed and then an ambiance temperature and relative humidity 
reading is performed. It is still possible to view the start of a new reading, without the initialization 
process. 
The following topics will explain each file of the developed firmware related to the sensors 
and oxygen saturation calculation, explaining its architecture and how each sensor works, 
including their SPI communication process. 
3.4.1.  Blood Oxygen Saturation Module 
This module is related to the AFE4400 firmware. This AFE needs four main different 
developed functions to work and acquired data from the sensor and sent it to the 
microcontroller. First, its slave select pins need to be initialized in the microcontroller as already 
presented in the main workflow diagram as “Initialization of AFE4400 slave select pins”. 
The second function has the objective to initialize the AFE4400 itself. This step is made 
according to four phases like the workflow in Figure 3.4.4 shows. The first step is reset all the 
registers, cleaning all the programming that was made in the last time that the system was 
powered up. Then it is made a check to know if AFE has any fault or not, returning a certain 
amount of bits to inform its status. These bits information was only used in initial tests. Then the 
microcontroller sends twenty seven timing control registers to set when each operation starts 
and ends, like is was explained in the Hardware section of this module. The last step before end 
the initialization process is to send five register related to the AFE400 operational mode 
defining some essential configurations. These registers can be changed to obtain different 
configurations, such as, for example, change the LEDs current or to activate/deactivate AFE4400 
SPI reading module.  
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Figure 3.4.4- Workflow diagram representing the AFE4400 initialization process.  
After the reset and initialization, two main functions are still missing, the reading and writing 
functions, also used in the initialization process, being responsible for the communication 
between the microcontroller and the AFE4400. To explain these functions it is important to 
understand how AFE4400 registers are designed by the manufacture: each register contains 32 
bits (4 bytes) where the first 8 bits (first byte) indicate the address of the register that is being 
sent and the remaining 24 bits (3 bytes) represent the information about that register. If it is a 
timing control register it contains the instant, inside a range, when the action defined by the 
register address must occur. Another example is when it is an operational register: in this case it 
will contain a first byte with the register address and then the information with the wanted 
configuration, being this chosen according to the datasheet, where all the possible 
configurations are described.  
The writing process in AFE4400 is made sending 32 bits from the microcontroller, divided in 
four groups of 8 bits due to the microcontroller architecture. 
The reading process is more complex. First, the AFE4400 must be set in the reading mode, 
sending a specific register which has a bit to configures the reading mode as active. When this 
register is sent, the reading mode turns on and only can be switch off when the same register is 
send with the opposite value of the same bit, inactivating the reading mode and activating the 
writing mode. With the reading mode active, to get a register from AFE4400 it is firstly needed 
to send the 8 bits that has the register address that is going to be read. After receive the register 
address, the AFE writes the information of the requested register in the next 24 clock cycles. 
These are read by the microcontroller and saved. The following image (Figure 3.4.5) is a 
captured SPI signal from the developed prototype, where a reading from AFE4400 is made. It is 
possible to see the slave select, named “ENABLE”, being activated (when it goes down) and the 
register request in the first 8 bits in the MOSI channel. After this, the remaining 24 bits are sent 
by the AFE4400 in the MISO channel, representing the information of the requested register. The 
initialization process use both writing and reading functions, being this last one only used to 
read the register that sends the faults flags checking. 
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Figure 3.4.5- - SPI digital acquisition showing the process to get a reading from AFE4400. First, 
AFE4400 slave select (“ENABLE”) is activated (value zero) and then the first 8 bits send the register 
address that the microcontroller wants to get the information. The next 24 bits are received by the 
microcontroller and represent the value of the requested register.  
To read the oxygen saturation sensor values it is only needed the reading function. The 
requested values were the LEDs samples without the ambient light contribution, being made 
two readings, one to get the Red led value and the other to get the Infrared value, both without 
the ambiance light contribution. Figure 3.4.6 shows the complete reading process with the 
writing of both registers addresses and respective sampled digital information. The separation 
between both registers is due to the sending process of the acquired value through Bluetooth 
that was activated to make some tests with the prototype sampled values. To decrease power 
consumption, the LEDs are only turned for the readings process. In Figure 3.4.6 is possible to see 
the ADC_RDY being activated when new values are ready to be read. Due to its independence 
with the reading process, fact proved experimentally, its connection was removed not being 
acquired by the microcontroller. It is important to mention that the samples acquired from the 
AFE4400 are converted into millivolts, according to the manufacture conversion. 
 
Figure 3.4.6- SPI digital acquisition of the process to acquire both needed readings to obtain oxygen 
saturation signal from the Red and the Infrared LEDs. The readings have some space after them due to a 
debug process that is not implemented in the final firmware version. The ADC_RDY is represented in the 
last channel and is constantly being actualized. After some tests, it was possible to verify its 
independence with the reading process, being disconnected from the microcontroller.  
After this firmware implementation, the signal obtained from the oxygen saturation sensor 
was acquired using a laptop, through a Bluetooth connection. Figure 3.4.7 shows the acquisition 
procedure to acquire the oxygen saturation curves, containing the VitalLogger prototype with 
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the oxygen saturation sensor connected and the laptop external Bluetooth device. The PComm 
Terminal Emulator software was used to acquire and record the values sent by the VitalLogger. 
 
Figure 3.4.7-Sampling acquisition procedure to acquire the oxygen saturation curve.  
The following figure (Figure 3.4.8) shows an example of 100 samples acquired from the 
finger using the VitalLogger prototype. This left image of this pictures shows the direct signal 
obtained from the oxygen saturation sensor. As explained in the oxygen saturation section 
(Figure 2.3.3), the PPG waveform is due to blood attenuation, decreasing it value when the blood 
flow increase. The most common and conventionally used PPG waveform is an inversion of this 
attenuation. The right image of Figure 3.4.8 shows the inverted waveform of the acquired signal. 
In the following representations of this signal it will be used the inverted representation. 
 
Figure 3.4.8- Oxygen saturation sensor acquisition with the VitalLogger prototype, showing the 
PPG waveform. The left image represents the acquired signal and the right image represents an 
inversion of this signal.  
The next step is to use the 100 samples of this process to calculate the oxygen saturation 
value. Before this step, some theoretical fundaments will be present to understand how oxygen 
saturation is calculate nowadays, and then the method used will be discuss as also the steps 
made until get to the final oxygen saturation value. 
Oxygen 
Saturation Sensor 
VitalLogger 
Prototype 
Laptop External 
Bluetooth 
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3.4.2.  Theoretical fundaments for SpO2 Calculation 
As it was presented in Chapter 2 (Figure 2.3.3), pulse oximetry is based on a light source that 
is attenuated by a DC component related to tissues, venous-blood and a continuous component 
of arterial blood that is non-pulsatile, and is also attenuated by an AC component that has a 
pulsatile behavior due to variations on arterial blood flow caused by heart beats that injects 
oxygenated blood in the circulatory systemic system originated from the circulatory pulmonary 
system. In oximetry, one of the causes that lead to the variation of this component value is the 
presence of hemoglobin and its derived molecules [90].  
In our blood exists several molecules derived of hemoglobin depending of which ligand is 
bind to the hemoglobin molecule. Two of these derived molecules are the one with a molecule of 
oxygen bound which is the most present in arterial blood, named Oxyhemoglobin (HbO2), and 
hemoglobin without any ligand, mainly present in the venous blood, named Deoxyhemoglobin 
(Hb). These two main derived of hemoglobin have different absorption spectra’s, like it is 
showed in the following image (Figure 3.4.9). [90, 91] 
 
Figure 3.4.9- Absorbance spectrum of oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) from 600nm 
to approximately 1000nm. The wavelengths used in pulse oximetry are represented in a red stripe for 
the Red source (660nm) and in a blue stripe the Infrared source (910nm). Adapted from [92]. 
As it can be seen, at approximately 660nm (Red), the absorbance of HbO2 is lower than Hb 
and at approximately 910nm (infrared) the opposite is verified. This fact is the main theoretical 
fundament that will allow obtain oxygen saturation. Pulse oximetry uses these two wavelengths 
to obtain the total intensity of each one of them. For the Red wavelength example, if the HbO2 
concentration is higher than the Hb concentration the total intensity absorbed will be lower, 
indicating a higher oxygen concentration. In the other hand, if the HbO2 decrease the Hb will 
increase and the total intensity absorbed will be higher, indicating a lower oxygen 
concentration. In the Infrared case, the opposite is verified because the HbO2 has a higher 
absorbance, so, if its concentration increases, the total intensity will also increase indicating a 
higher oxygen concentration. In this case, the intensity increasing is going to be lower than in the 
Red LED. [90, 91] 
Pulse oximeters sensors have LEDs with these to wavelengths and photodiodes to receive 
both of these wavelengths. As it was shown in the cycle of AFE4400, pulse oximeters emit these 
Absorbance 
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two wavelengths separately and acquire each signal to obtain the total intensity of each 
wavelength. The oxygen saturation percentage is based on these intensities using its ratio to 
obtain a correlation between the concentration of HbO2 and Hb. This ratio is described by the 
literature as the “R value”, and is a simplified equation that allows to correlate its value with the 
oxygen saturation percentage. Equation 1 shows the R value calculation for the wavelengths of 
the sensor used in this work. [91] 
𝑅 =
(
𝐴𝐶
𝐷𝐶
)≈660𝑛𝑚
(
𝐴𝐶
𝐷𝐶
)≈905𝑛𝑚
   (Eq.1) 
The R value correlation with the oxygen saturation is then obtained through a pulse oximeter 
calibration curve. Figure 3.4.10 shows an example of a calibration curve, and its correlation is 
normally made with a second degree equation, like it is made in this work. 
 
Figure 3.4.10- Example of an oxygen saturation curve that correlates the R value with the oxygen 
saturation level with a polynomial second degree equation. Adapted from [91] 
 The R value calculation can be made using three different mathematical operations using the 
PPG signal obtained from the pulse oximeter sensor. The first one is to use the AC amplitude in 
both wavelengths in the R equation. Knowing that the amplitude is gave by the maximum and 
minimum value of AC component, where the minimum value corresponds to the DC value. 
Another method is based on the same logic, but applied to parts of the PPG signal instead of its 
application in a complete PPG wave like in the previous method. This method allows to compute 
the R value along its acquisition and with less motion artifacts, which is a better approach in real 
time monitoring application. Both of these methods were tested in this work and one was 
chosen one of them to be implemented like it will be discussed in the next topic. A third method 
to get the R value uses the Fast-Fourier Transform (FFT) computation, correlating the intensity 
of specific frequencies. This method was put aside from the beginning due to the high 
computation cost of the FFT calculation for the main board microcontroller, not being analyzed 
in this project. [91] 
To better evaluate which of the first two mentioned methods where the best to get the R 
value, it was made a MATLAB script to make this evaluation automatically. This evaluation will 
be discussed in the following topic, explaining all steps made and results obtained. 
SpO2=AR2+BR+C 
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3.4.3.  Evaluation of the Best Method to Calculate the R Value 
In this section two methods for the R value calculation are evaluated, one based on the 
maximum and minimum value (MaxMin Method) and the other that gets a certain number of 
samples of the PPG signal and calculates the R value (By Parts Method). To better evaluate these 
methods, this analysis was made already with acquired values from the prototype sensor 
develop in this project. After values acquisition it was made a MATLAB script to first make a 
signal analysis and processing using basic operations, to then transform it in C language and 
implement in the microcontroller the best processing method and the best R value calculation 
method. 
To obtain a more robust decision of which is the best method to calculate the R value it was 
acquired SpO2 signals at different heart rates (Beats Per Minute - BPM) and at different oxygen 
saturation levels. These experimental values were obtained using a SpO2 simulator, which will 
be deeply discussed in the Sensor Calibration section. It is important to refer that the simulator 
used has defined values for BPM and SpO2 values (Table IV). For each SpO2 value it was acquired 
a PPG simulated signal at all the BPMs values possible to be simulated, being described both 
variables range on the following table. 
Table IV- Values of Oxygen Saturation levels and heart rate (BPM) levels simulated by the simulator 
device. For each value of these two variables the other variable can assume all the referred values. For 
example, for a 70% of oxygen saturation, it is possible to simulate this level in all the heart rate levels 
presented in the table.  
SpO2 values (%) 
 Heart rate 
values (BPM) 
70 30 
75 60 
80 65 
85 80 
90 100 
95 120 
97 150 
98 180 
99 240 
100  
 
Before the R value calculation some signal process was made according to the signals 
obtained in the SpO2 simulator, as also using samples acquired from a finger. Figure 3.4.9 shows 
the workflow of the signal processing made. 
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Figure 3.4.11- Workflow diagram representing the signal processing made until the R value 
calculation. 
The designed workflow was developed to allow the use of this signal processing in all the 
BPMs acquired in the simulator, choosing a fixed number of samples in average filters according 
to its analysis and to human signals. The first operation (“Mean Filter”) objective is to smooth 
the acquired value, removing some high frequency noise. Then, a normalization process is made 
to obtain a more similar DC value between both LEDs signals, equalizing the reference value and 
obtaining a more consistent value in the R value calculation. After this a mean filter with a high 
number of samples (N=19) is applied to get a mean line of the signal. The last step is to subtract 
this line to the original signal, obtaining a signal with a constant baseline and removing some 
signal oscillations (low frequencies). Figure 3.4.12 shows an acquisition from a finger in 
movement to illustrate this process implementation in MATLAB. This signal processing allows 
removing signal originated by the finger movement, leading to a more feasible R value 
determination. 
The next and last step was to calculate the R value. Both methods were already explained, 
only is missing the number of samples used in the “By Parts Method”. Several tests were made to 
achieve the best number of samples and in the end it was considered 5 samples. This value was 
achieved testing several sampling numbers at the several BPMs values and a sampling of 5 
values showed the best results regarding the variation of the oxygen saturation levels. Even 
though this was the sampling window with best results, one value at 30 BPM was very different 
from the expected value. Table V shows the mean results obtained in the R value calculation for 
each oxygen saturation level, considering all the simulator possible BPM. To obtain these results, 
the outside value at 30 BPM was replaced by a medium value between the next and the previous 
oxygen saturation R value obtained. 
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Figure 3.4.12- Example of the signal processing steps made before R value calculation  using a signal 
acquired on a human finger with the developed prototype . To obtain this signal the number of samples 
restriction was increased to 150 and the finger was moved during the acquisition. The first image (top 
left) represents the signal acquired by the prototype. The second image (top right) shows the signal 
after the first mean filter (N=3). The third image (bottom left) shows the normalization result of both 
waves. The last image (bottom right) represents the final signal after the baseline construction.  
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Table V- This table shows the mean values and respective standards deviation of the R value result for 
each oxygen saturation level when the heart rate frequency goes from 30 to 240 BPMs according to the 
simulator scale. The R value is calculated using two methods, “MaxMin” and “By Parts” in order to 
analyze the best method to calculate the R value.  
Oxygen 
Saturation 
MaxMin Method By Parts Method (n=5) 
Mean Standard Deviation Mean Standard Deviation 
70 10.55 3.05 10.78 3.91 
75 10.01 2.94 12.74 5.50 
80 9.23 2.74 8.94 2.94 
85 8.41 2.64 7.56 2.28 
90 7.18 2.20 6.19 2.41 
95 5.77 1.78 7.41 4.72 
97 5.26 1.57 4.45 3.07 
98 5.09 1.60 5.98 4.48 
99 4.70 1.43 4.27 1.21 
100 4.34 1.30 3.66 1.21 
 
Analyzing the previous table (Table V) it is possible to conclude that the “MaxMin Method” 
has better results due to its increasing consistence and lower standard deviation along the BPM 
variation. “By Parts Method” also shows good results, but not as good as the “MaxMin”. To get a 
more consistent conclusion, and after an analysis of the oxygen saturation in each BPM, it was 
made the same comparison between these two methods without the R values from 30 and 240 
BPMs as it is showed in the following table (Table VI). 
 
Table VI- This table shows the mean values and respective standards deviation of the R value result 
for each oxygen saturation level when the heart rate frequency goes  only from 60 to 180 BPMs according 
to the simulator scale. The R value is calculated using two methods, “MaxMin” and “By Parts” in order to 
analyze the best method to calculate the R value.  
Oxygen 
Saturation 
MaxMin Method By Parts Method (n=5) 
Mean Standard Deviation Mean Standard Deviation 
70 11.50 0.40 11.10 2.42 
75 11.01 0.44 15.28 2.98 
80 10.03 0.36 10.34 0.82 
85 8.99 0.37 8.27 0.83 
90 7.69 0.30 7.20 1.60 
95 6.17 0.24 8.10 4.37 
97 5.78 0.21 5.72 2.31 
98 5.40 0.17 7.02 4.70 
99 5.14 0.38 4.69 0.90 
100 4.72 0.17 4.18 0.64 
 
The obtained values in Table VI confirm that the first method has better results in the R value 
calculation due to its low standard deviation when the BPM range was changed. These results 
led to choose the “MaxMin Method” to be implemented in the microcontroller to calculate the R 
value, joined with all the previous presented signal processing. 
After its implementation, samples from the microcontroller calculated R value where acquire 
to compare its values with the obtained using the MATLAB script and the results were very 
positive, obtaining a very small error percentage. The following figure (Figure 3.4.13) shows the 
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results of an acquisition at different oxygen levels at 80 BPMs. The table presented (Table VII) 
compares, for the same acquisition, the R values calculated using the MATLAB script with the 
ones acquired directly from the prototype in a laptop through a Bluetooth connection. 
 
Figure 3.4.13- Photopletismograph signal obtained using the developed prototype and acquired from 
the oxygen saturation simulator at 80 BPMs. In this case, the signal processing and R value calculation 
(“MaxMin Method”) were both made using the developed MATLAB script. The abscissa values correspond 
to the number of the sample and the ordinate values to integer values acquired from the sensor, but 
these do not represent the acquired voltage.   
Table VII- This table shows the R values obtained for each oxygen saturation level at 80 BPMs in the 
oxygen saturation simulator. The R values presented in the “MATLAB” column are the ones calculated 
using the MATLAB script and the values obtained directly from the microcontroller on the developed 
prototype are represented in the “Prototype” column. The last col umn shows the error percentage of 
Prototype obtained values in relation to the values obtained using the MATLAB script. 
Saturation 
R value 
Error (%) 
MATLAB Prototype 
70 3.728 3.728 0.00461 
75 3.363 3.364 0.0249 
80 3.079 3.080 0.0259 
85 2.690 2.690 0.00119 
90 2.409 2.409 0.0131 
95 1.886 1.886 0.00297 
97 1.713 1.739 1.48 
98 1.701 1.701 0.0153 
99 1.569 1.569 0.0204 
100 1.477 1.477 0.0133 
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3.4.4.  Ambiance Temperature and Relative Humidity Module 
The HIH6130 sensor firmware is less complex than AFE4400 due to its acquisition autonomy. 
This sensor does not need to receive any register from the microcontroller to configure its 
operating mode and does not even need MOSI SPI channel, being totally autonomous in its 
configuration due to the lower complexity to sample the ambiance variables. The firmware of 
this sensor is mainly divided in two files: one to initialize the microcontroller slave select pins of 
HIH6130 and the second one to acquire a sample from the sensor. 
 
Figure 3.4.14- Workflow diagram representing the HIH6130 reading cycle.  
 
 
Figure 3.4.15- SPI digital acquisition of the HIH6130 reading cycle, where the slave select channel  is 
represented by the “ENABLE” channel. The time distance between the measurement request command 
and the reading is approximately 50ms as it can be seen in the “width” measurement represented in the 
right corner of the figure.  
Figure 3.4.14 and Figure 3.4.15 show the HIH6130 acquisition process. It consists in two 
phases: the first phase is a simple 8-bit clock signal (Figure 3.4.16) to wake-up the sensor; and 
request a temperature and relative humidity reading. During this process the MISO SPI channel 
data is ignored due to its insignificant data in this phase.  
 
Figure 3.4.16- SPI digital acquisition of the HIH6130 data request made by the microcontroller.  
 Firmware Development 
73 
 
After request a measurement it is needed to wait approximately 50ms to let the sensor make 
a complete environment reading and convert it in digital signal. Passed more or less 50ms a 
reading in the SPI MISO channel can be done (Figure 3.4.15). This reading consists in a 64 bits 
reading. The first 32 bits are to acquire temperature values and the 32 remaining bits are to 
acquire the relative humidity values. In these two segments of 32-bit only a few bits really 
represents the wanted variable. In the 32-bit of temperature only the bits from bit 15 to bit 2 
contains the temperature value and in the 32-bit segment of relative humidity, its value is 
contained from bit 13 to bit 0. The following figure (Figure 3.4.17) shows the SPI communication 
during this process. 
 
Figure 3.4.17- SPI digital acquisition of the HIH6130 reading process. First 32 -bit represents the 
temperature reading and the remaining 32-bit represents the relative humidity reading.  
After the isolation of the both 14-bit segments, temperature and relative humidity, its 
conversion to real values, according to the manufacture, is performed using equations 2 and 3 
respectively [88]. 
 
𝑇𝑒𝑚𝑝𝑒𝑟𝑎𝑡𝑢𝑟𝑒 (°𝐶) = (
14_𝑏𝑖𝑡 𝑇𝑒𝑚𝑝𝑒𝑟𝑎𝑡𝑢𝑟𝑒 𝑠𝑒𝑔𝑚𝑒𝑛𝑡
214−2
∗ 165) − 40         (Eq.2) 
 
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝐻𝑢𝑚𝑖𝑑𝑖𝑡𝑦 (%𝑅𝐻) =
14_𝑏𝑖𝑡 𝑅𝑒𝑙𝑒𝑡𝑎𝑖𝑣𝑒 𝐻𝑢𝑚𝑖𝑑𝑖𝑡𝑦 𝑠𝑒𝑔𝑚𝑒𝑛𝑡
214−2
∗ 100        (Eq.3) 
 
Although this sensor description says that the obtained values are already calibrated, a 
validation will be done to confirm the values acquired. This will be presented in the Sensors 
Calibration and Validation section. 
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3.4.5.  Gyroscope Module 
Although this sensor was not implemented as already mentioned, its functionalization was 
study and analyzed, creating a prototype of its firmware implementation. LSM330DLC working 
workflow is similar to the AFE440 but with a simple initialization process and each register with 
only 16 bits (Figure 3.4.18). 
 
Figure 3.4.18- Workflow diagram representing the working cycle of LSM330DLC gyroscope sensor. 
First it is represented the initialization process and then the reading process.  
The initialization is divided in the initialization of slave select pins in the microcontroller and 
then the operating mode registers are sent, each one, in two groups of 8-bit, one with the 
address and the other with the register information. These operating mode registers are eight, 
and only control the gyroscope module of LSM330DLC, since it would be the only variable 
acquired from this sensor. If the accelerometer was also needed it were going to be sent more 
control registers to set the operating mode of the accelerometer module of this sensor. After the 
initialization, that only needs to be done when the circuit powers on, the acquisition can be 
made continuously. To read gyroscope samples it is sent the register address related to the 
required variable and then 8 bits are returned and read with the requested variable value. In 
this acquisition are requested five values of the gyroscope sensor: the X, Y and Z axis, as also the 
sensor temperature and the sensor status to see if the read is new or the same as the last 
reading, informing if the sampled data is valid and different from the previous acquired. It is 
important to refer that each X, Y and Z variable has 16 bits, and so, to get a complete sample, two 
different registers are needed to be sent to acquire a sample from each axis. 
As this sensor was not implemented in this prototype, it will not be presented in the next 
section of sensors calibration and validation. 
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3.5.  Sensors Calibration and Validation 
The calibration and validation of the implemented sensors is very important, mainly in the 
SpO2 sensor because it needs to have a calibration curve to be accurate to and allow a possible 
future use as a medical device.  
To make the calibration and validation of both sensors it was needed to search for similar 
commercial sensors to compare obtained values and in the SpO2 also an oxygen saturation 
simulator to obtain the calibration curve.  The validation procedure is going to be supported by 
the Bland Altman plot [93], a method used to quantify the agreement between two quantitative 
measurements. This statistical analysis was made using MedCalc software. 
 All these topics and all the methods and tests performed are going to be discussed in the 
following topics, first for the SpO2 sensor and then for the ambiance temperature and relative 
humidity sensor. 
3.5.1.  Blood Oxygen Saturation  
Blood Oxygen Saturation is a medical measurement that needs to be highly accurate to 
provide correct physiological information. The calibration process consists in the construction of 
a correlation between the calculated R value and the percentage of oxygen in blood. To do such 
correlation, an oxygen simulator is needed to simulate several specific oxygen levels and 
correlate the R value obtained with the simulated levels. To simulate oxygen saturation levels a 
ProSim SPOT Light from FLUKE [94] was used. The characteristics of this device will be referred 
in the following topic where the sensor calibration is discussed.  After prototype sensor 
calibration the next step was to validate its oxygen saturation measurements in a human finger 
and comparing its results with a commercial oxygen saturation device used in medical 
environment. For this measurement validation it was used the model M3046A from Philips [95], 
a compact portable patient monitor used to monitor patients physiological signs in the hospital. 
It is important to refer that all these tests, calibrations and validation procedures were made 
in Hospital de São João, in their Metrology Laboratory, the Hospital section responsible by the 
calibration of all the hospital medical devices. 
3.5.1.1.  Sensor Calibration 
As mentioned above, a FLUKE ProSim SPOT Light was used to simulate oxygen saturation 
levels. The oxygen saturation sensor probe is attached to a small probe in the simulator to 
acquire simulated values. One side of this probe has light sensors (photodiodes) to read oxygen 
saturation LEDs intensity and periodicity of each LED. The other side has LEDs with an pulsatile 
intensity that depends of the oxygen saturation sensor LEDs intensity minus the simulation of 
the absorbed intensity according to the oxygen saturation level selected in the simulator. 
Resuming, it is an inversion of an oxygen saturation sensor with an emission of simulated values. 
This specific simulator device, beside different oxygen saturation levels, can also simulate 
different heart rates (Table IV), perfusions levels, finger sizes and can also simulate artifacts like 
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50Hz or 60Hz noise. Figure 3.5.1 shows an image of the FLUKE simulator with the prototype. 
This image shows the prototype and the FLUKE simulator device during the calibration process. 
 
Figure 3.5.1- This image shows the FLUKE simulator device and the prototype during the calibration 
process. The prototype was connected with a laptop thro ugh a Bluetooth connection, sending the 
calculated R values. 
For this calibration procedure only oxygen saturation and heart rate were changed from the 
simulator initial configuration to create the calibration curve which correlates the calculated R 
value with the Oxygen Saturation level. For each heart rate frequency the oxygen saturation 
levels were changed according to the values that were possible to simulate. For each different 
combination of heart rate and oxygen saturation level the R value was acquired in a laptop 
directly from the developed prototype through a Bluetooth connection. The following figure 
(Figure 3.5.2) shows the calibration curve obtained with the oxygen saturation values simulated 
by FLUKE device, with the respective standard deviation according to the variation of heart rate 
between 60BPM and 180BPM. 
Oxygen 
Saturation Sensor 
Oxygen Saturation 
Simulator Device 
VitalLogger 
Prototype 
Laptop External 
Bluetooth 
 
Simulator 
Device Probe 
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Figure 3.5.2- Graphical representation of the correlation between the R value obtained from 60 to 
180 BPM (differences represented by the standard deviation) and the oxygen saturation level. The 
respective trendline and square error from the acquired samples are below the graphic legend.  
The calibration curve obtained has a high correlation value (R2=0.9968) when the saturation 
value is between 70% and 100% and the heart beat between 60 and 180BPM, with a small 
standard deviation between those BPM.  
After the implementation of this calibration curve in the microcontroller firmware it was time 
to make the test with a real finger. When these tests were made a problem was detected: the R 
value was not a constant value between acquisitions; and when the sensor position was 
changed, even with small movements, the R value changed its greatness, indicating, in both 
cases, a wrong oxygen saturation value. To try to understand this problem the prototype was 
extensively tested in the oxygen simulator to observe the R value behavior. In these tests the R 
value showed consistence in its values, but when the position on the simulator was changed, the 
values showed also consistence when the saturation level was increased but in a higher or lower 
range. For example, in a certain position the R value range was from 5 to 15 (Figure 3.5.3 – left 
image) and when that position was changed the R value range was only from 1.5 to 3.7 
approximately (Figure 3.5.3 – right image). 
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Figure 3.5.3- Two different calibration curves obtained due to a different position in the simulator 
probe. For these tests it was used only the oxygen saturation level s at 80 BPMs. 
To try to understand this problem it was investigated the difference in the simulator between 
the developed prototype and a conventional oxygen saturation device used in a medical 
environment, being this last one connected to the simulator. When this test was done a 
difference was spotted: the light intensity indicated by the simulator was much higher compared 
to the developed prototype sensor intensity. This fact was considered plausible to be the cause 
of why different positions in the simulator were changing the R value, leading to different 
calibration curves. This intensity problem also explains why small position deviations presented 
wrong oxygen saturation levels. 
To overtake this problem, some registers of AFE4400 were change to increase LEDs intensity. 
At the first tests the LEDs were with a current supply of 3.9mA, and it was increased to 35mA, of 
a maximum value of 50mA, equalizing the visual light intensity of the conventional oxygen 
saturation device used. When this was done another problem was spotted: the main board 
Bluetooth, after more or less a minute with the LEDs at 35mA, crashes and re-initialize, 
interrupting data transmission. After some tests and LEDs current variations, it was concluded 
that the main board did not provide the amount of current needed when the LEDs had more 
than 20mA of current supply. Since the main board power management was design to limit the 
current supply to 200mA, it was necessary to change the power management. To do this change 
it was acquired and mounted a different voltage regulator, with a higher current supply limit of 
400mA. While this process was in progress, the device with the original power management was 
used to analyze the R value obtained with LEDs current with about 15mA. Although, with this 
current supply, the LEDs had a lower light intensity compared with a conventional oxygen 
saturation device, the R value obtained was much less discrepant and when the sensor position 
was changed in the finger only small variations were observed. While the new power 
management was being implemented, to improve the R value regarding the sensor position in 
the finger, it was made an automatic LEDs intensity adjustment allowing maintaining a pre-
defined range in the receiving sensor. This automatic adjustment was included in the main 
firmware workflow after the verification of the finger in the sensor. 
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Figure 3.5.4- Workflow diagram of the automatic adjustment of the sensor LEDs supply current. This 
is performed after verifying that the finger is inserted in the sensor. After the acquisition of HIH6130 
the “Adjustment made” is equaled to “no”. The samples acquired in this procedure are not use in the 
oxygen saturation calculation, for which 100 samples are n eeded.  
As figure 3.4.5 shows, only if the acquired values are out of the required sampling range, it is 
firstly made an adjustment to LEDs supply current based on the Infra-Red value acquired, and 
then an adjustment is made using the Red value acquired. LEDs current variation can be a high 
or low adjustment, according to the difference between the acquired samples and the wanted 
sampling range. It is important to refer that the LEDs power supply changing is always the same 
for both LEDs, obtaining no difference in the light emission intensity between these two 
wavelengths. After the implementation of the LEDs adaptive light intensity function it was 
possible to obtain the R value inside the same range, without variations regarding the sensor 
position. This light intensity adaptation also increase the viability of this sensor for different 
finger sizes, adapting LED’s intensity to acquire always samples inside the same range. 
When the new voltage regulator was assembled, it was possible to increase LEDs intensity 
and also increase the pre-defined intensity range in the receiving sensor to regarding the 
automatic LEDs intensity adjustment. After this, it was performed a new calibration curve as 
shown in Figure 3.5.5. With this higher intensity it was verified a much lower standard deviation 
and it was possible get a calibration curve with a BPM range from 30BPM to 240BPM, increasing 
the viability of the developed sensor. 
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Figure 3.5.5- Calibration curve obtained with the new calibration made using the new voltage 
regulator.  The respective trendline and square error from the acquired samples are below the graphic 
legend. 
After this calibration procedure, the validation of the prototype oxygen saturation sensor was 
performed, comparing it with a commercial device used in medical environment as it will be 
discussed in the following topic. 
3.5.1.2.  Sensor Validation  
Sensor validation is very important to confirm that the oxygen saturation levels obtained 
with VitalLogger prototype device are the same as a medical device used in a medical 
environment. To validate the prototype it was used a medical device from Philips, model 
M3046A, performing two tests. For both tests the procedure was to insert the left index finger in 
the Philips SpO2 sensor and the right one in the VitalLogger SpO2 prototype sensor. When a 
reading was made by the prototype, more or less 6 seconds, the oxygen saturation values from 
both devices were annotated. The following image (Figure 3.5.6) shows the apparatus used in 
the validation procedure, where both devices are presented, with the respective SpO2 sensors. 
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Figure 3.5.6- Apparatus used in the validation procedure of the oxygen saturation values. In this 
image it is possible to see the Philips device with its SpO2 sensor and the VitalLogger Prototype also with 
its SpO2 sensor. The external laptop Bluetooth is also present to acquire VitalLogger transmitted data.  
For the first test, one hundred samples were saved from the same person, obtaining the result 
presented in Figure 3.5.7. To try to simulate different oxygen saturation values the breath was 
not constant. The results obtained in this test were very similar between both devices, with an 
average error percentage of approximately 0.5%. Although, almost 50% of the prototype 
saturation percentage acquired values were different from the medical device values, this 
difference is only 1%, which can be considered a very small difference. 
 
Figure 3.5.7- First test experimental results obtained during the acquisition of oxygen saturation  
percentage values to validate the prototype values. This image presents the values from VitalLogger 
prototype and Philips device during the acquisition of one hundred samples.  
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To better analyze these data, it was performed a Bland Altman analysis which consists in a 
plot analysis where the difference between both measurements (Philips device and VitalLogger) 
is correlated with the mean of the same measurements. Bland Altman plot shows an agreement 
interval between ±1.96 of the standard deviation (SD) of the differences, where 95% of the 
differences should be between them (with a confidence interval (CI) of 95%) when considered 
that the difference is normally distributed. he normal distribution is evaluated using the 
D’Agostino-Pearson test (if P<0.05 the normality is rejected) [93]. The following figure 3.5.8 
shows the Bland Altman plot (left side) and the distribution plot of differences between both 
measurements (right side). 
       
Figure 3.5.8- On the right side is represented the Bland Altman plot ( blue line-mean difference; red 
lines- limits of agreement; red dotted line- mean difference CI; blue dotted line- limits of agreement CI). 
On the left side a distribution plot of the differences is presented. Although normality is not accepted 
according to D’Agostino-Pearson test (P=0.0465), due to its very small difference from normality 
acceptation the Bland Altman plot was done considering that the differences are normally distributed.  
By observing both plots in Figure 3.5.8 it is possible to see that 95% of the acquired 
measurements are inside the agreement limits, and the remaining 5% are almost inside the CI of 
the lower agreement limit. These samples have a similar difference behavior along the increase 
of the several values of measurement, and due to a mean higher than zero, it is possible to 
assume that VitalLogger prototype values have a higher probability to acquire one value below 
the Philips device values than above it. This could be improved by making another calibration 
curve or a small adjustment according to these data. 
A second test was made to simulate a small acquisition from a patient. This consisted in the 
acquisition of only twenty samples from another person to verify the adaptation of the 
VitalLogger prototype to different fingers (Figure 3.5.9). The results from the developed sensor 
are also very similar to the medical device used, obtaining a smaller average error than in the 
previous test, of 0.41%. In this case, 40% of the prototype saturation percentage acquired values 
were different from the medical device values, the difference only deviate in 1%, a very small 
difference.  
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Figure 3.5.9- Experimental results obtained during the second test made in the validation procedure. 
This image presents the values from VitalLogger prototype and Philips device during the acquisition of 
twenty samples. 
Regarding the Bland Altman plot, Figure 3.5.10 shows the obtained results, joined with the 
distribution plot of differences between both measurements (right side). 
      
Figure 3.5.10- On the right side is represented the Bland Altman plot (blue line-mean difference; red 
lines- limits of agreement; red dotted line- mean difference CI; blue dotted line- limits of agreement CI). 
On the left side a distribution plot of the differences is presented. Normality of the dif ferences is 
accepted according to D’Agostino-Pearson test (P=0.9693). 
In this case, Figure 3.5.10 shows that all the acquired values are inside the agreement limits , 
showing also a consist of the differences along the increase of the acquired values. Although this 
acquisition has lower number of samples, the mean of the differences is lower than zero, the 
opposite behavior than in the previous acquisition. To better understand the real behavior 
between these two devices, if VitalLogger prototype as the tendency to get a lower or higher 
value than Philips device, a larger number of samples should be acquired to different subjects. 
With both of these tests it is possible to affirm that the developed oxygen saturation sensor is 
capable to acquire SpO2 values almost as good as a conventional medical device normally used in 
  
 
 
Chapter 3 - VitalLogger: An adaptable Wearable Health Device  
84 
 
the hospitals, varying only one percent above or below. It would be of great interest to validate 
this prototype on patients with lower oxygen saturation levels than the normal ones, evaluating 
the prototype behavior. 
3.5.2.  Ambiance Temperature and Relative Humidity Validation 
The calibration and validation of this sensor values was easier than the SpO2 due to the 
simplicity to get the wanted final values, reading already the values of the ambiance temperature 
and relative humidity directly from the sensor. According to the sensor manufacture the values 
obtained are already the right ones and don’t need a calibration process. Even thought, to 
analyze this sensor accuracy a validation procedure was performed. As it will be discuss, after 
this test it was concluded that a small calibration on the outputted values from the sensor was 
needed.  
To compare the obtained values from the prototype, it was used a commercial device 
DVM8010 produced by Velleman [96], which provide temperature and relative humidity 
measurements. To simulate a small atmosphere where relative humidity and temperature could 
be changed, it was used a small transparent sealed reactor (Figure 3.5.11) from chemical 
engineering laboratories on the Chemical Engineering Department from the Faculty of 
Engineering of the University of Porto. Temperature limitation of this container and also its 
construction material did not allowed to change the temperature using a hot source. Due to this, 
the procedure to change the temperature, and mainly the relative humidity was expiring air 
from the lungs into the container using its unique opening located in the plastic tube on the 
bottom of the reactor as Figure 3.5.11 shows.  
 
Figure 3.5.11- In this image it is possible to observe the Velleman device and the developed 
prototype inside the container to simulate a different atmosphere from the one in the outside.  
The procedure was based on the expiration of some air into the container through the plastic 
tube to increase the humidity and temperature value. When an increase was verified some 
VitalLogger 
Prototype 
Velleman Device 
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seconds were waited until the stabilization of the Velleman device. When this stabilization was 
verified, a temperature and relative humidity reading was made from this device and from the 
prototype. Along the increase of relative humidity more expired air was needed to raise even 
more this value. After reaching a value where some breaths did not change significantly the 
acquired values, both sensors were removed from the container and samples were taken along 
time. When a stabilization was observed the values where sampled and a small air flow was 
induced in both sensor at the same time, in order to mixed the air inside the sensors with the 
ambiance air. This procedure was repeated while a decreasing of ambiance relative humidity 
was verified, always waiting some seconds until Velleman device stabilization. It is important to 
refer that the air flow to mix the air inside the container was also perform with strong 
expirations. 
Both sensors were kept together as Figure 3.5.12 shows for the case when the sensors were 
inside the container. Sensors proximity allows to remove any measurement difference due to 
different air properties. 
 
Figure 3.5.12- This image shows both devices sensors, visualizing their high proximity. In the red 
circle is the prototype HIH6130 sensor and in the blue circle is the Velleman device air entry. 
Regarding the samples obtained, the described procedure was made two times and the 
results are presented on the following image (Figure 3.5.13). 
 
Figure 3.5.13- Graphical representation of the samples acquired from the Velleman device and the 
developed prototype during the procedure above described.  
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Analyzing the data acquired in Figure 3.5.13 it is possible to conclude that both sensors have 
a similar behavior, but the prototype present different values from the obtained with the 
Velleman device. To get better values a calibration was made to the developed prototype with 
the aim to obtain a smaller difference in the values acquired. Two correlation curves were made 
to perform a calibration, one for the temperature and another for the relative humidity (Figure 
3.5.14) 
  
Figure 3.5.14- Calibration curves obtained from the experimental results presented in Figure 3.5.5. 
The left image represent a graphical representation of the samples from Velleman device versus the 
developed prototype and the respective regression line. The right image shows the same relation but for 
the relative humidity samples.  
In the relative humidity calibration curve the first five samples were not considered due to a 
high deviation from the value measured with the Velleman device, obtaining a calibration curve 
with a better correlation. Also the values acquired with the prototype in those samples are not 
according to the obtained after at the same relative humidity measured with the Velleman 
device. The following figure (Figure 3.5.15) shows the same samples acquired, but with the 
correlation curve implemented, observing a much higher similarity between both sensors. 
 
Figure 3.5.15- Graphical representation of the obtained values after the adaptation of the regression 
lines. The calculation was made in the computer applying the regression lines to the already obtained 
samples values. 
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After this test, a Bland Altman analysis was made with these new better correlated between 
both devices acquired data. As already present in the oxygen saturation sensor validation, the 
following figures (X and Y) shows the shows the Bland Altman plot in the left side and the 
distribution plot of differences between both measurements in the right side. This analysis is 
firstly made for the temperature and then for the relative humidity. 
       
Figure 3.5.16- On the right side is represented the Bland Altman plot (blue line -mean difference; red 
lines- limits of agreement; red dotted line- mean difference CI; blue dotted line- limits of agreement CI). 
On the left side a distribution plot is presented. Although normality of the differences is not accepted 
according to D’Agostino-Pearson test (P=0.0473), due to its very small difference from normality 
acceptation and shape, the Bland Altman plot was done considering that the differences are normally 
distributed. 
Plots presented in Figure 3.5.16 shows a high agreement between both devices, obtaining all 
the differences of the acquired samples from both devices inside the agreement limits, with a 
mean of almost zero. These god results can be due to a low range of ambiance temperature 
values, being necessary to perform future tests with a higher range of temperature values.  
 
        
Figure 3.5.17- On the right side is represented the Bland Altman plot (blue line -mean difference; red 
lines- limits of agreement; red dotted line- mean difference CI; blue dotted line- limits of agreement CI). 
On the left side a distribution plot of the differe nces is presented. Normality of the differences is 
accepted according to D’Agostino-Pearson test (P=0.5561). 
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The Bland Altman plot in Figure 3.5.17 shows that all the differences, except one, of the 
acquired values from both devices, are inside the agreement limits. Also it is possible to visualize 
a mean of differences very close to zero, showing a high similarity between values acquired from 
the Velleman device and the VitalLogger prototype. 
 After this analysis, the temperature and relative humidity calibration curves were 
implemented in the sensor firmware. To better calibrate this sensor and obtain ambiance 
temperature and relative humidity values with a higher accuracy, a precise test should be 
performed with a higher range of these two variables to validate, and if needed, to calibrate the 
sensor in a larger scale for both temperature and relative humidity variables. 
  
 Prototype Specifications Analysis 
89 
 
3.6.  Prototype Specifications Analysis 
To better understand the possible future viability of the developed prototype, this topic is 
going to present its characteristics as also it associated costs. In this analysis it will be 
considerate the second version of the VitalLogger extension board presented in Appendix. 
The associated costs can be divided in three main components: Oxygen Saturation sensor; 
Printed Circuit Board (PCB); and the electronic components. Oxygen saturation sensor has a 
high cost variation depending where it is both. If it is both in China or another Asiatic Country 
where the sensor is produced the costs range is approximately from 10€ to 30€, depending on 
the company where the acquisition is made and also of the requested quantity of sensors. On the 
other hand, if the acquisition is made in a Portuguese distributor the costs increase until 150€ 
approximately. The costs associated to the PCB’s and the electronic components also change 
according to the number of units requested. The following table (Table VIII) resumes the 
associated cost for the electronic components needed and PCBs according to the produced units 
of VitalLogger second version prototype.  
Table VIII- This table shows the associated costs of the VitalLogger second version prototype 
regarding the electrical components and PCB costs per each unit produced according to the number  of 
units produced. In the last column of the table a total cost per unit is presented.  
Produced Units 
Electrical Components 
Cost per unit 
PCB Cost per unit 
Prototype Cost 
per unit 
10 34.54 € 8.27 € 42.81 € 
50 30.51 € 3.36 € 33.87 € 
100 26.90 € 2.32 € 29.22 € 
 
As the table below shows, a production of only 10 prototypes is expensive compared to the 
production of one hundred, mainly due to the electrical components. This could be resolved with 
the reduction of the electronic components as it was already referred for the power 
management case. If this circuit module was removed the components cost would decrease 
obtaining a cheaper prototype price. This aspect will be discussed in the following topic, where a 
new prototype is proposed, with a much lower cost. 
Regarding electrical characteristics, mainly the consumption requirements it can be divided 
in two main contributions: electronic components consumption; and sensor LED consumption. 
The first one related to the electronics consumption, making a battery life-time estimation 
regarding the consumption properties of each component used, obtaining approximately 4.2mA. 
Knowing that the main board from Biodevices, S.A. has a current consumption of about 30 mA, 
already with the Bluetooth and SD memory card both on, and using a 1000mAh battery, it would 
be possible to use this prototype during, approximately, 29 hours in continuous acquisition, 
storing and transmission. The second contribution is from the oxygen sensor by its LEDs. These 
can suffer small variations from user to user according to the light intensity needed and also 
because the LEDs are only on when the reading is being done, which difficult the consumption 
time estimation. To obtain a practical and correct battery life-time estimation, VitalLogger 
prototype was be submitted to a battery life test. For this test the battery was totally charged 
and then turned on. To simulate a finger inserted in the sensor it was inserted a paper in the 
oxygen saturation sensor. The Bluetooth was turned on but was not connected to any device, 
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obtaining 15 hours of continuous measurement from all the VitalLogger prototype variables. 
More battery life-time tests should be done to know how long can the prototype continuously 
acquired samples and send it via Bluetooth.  
The final VitalLogger prototype is presented in Figure 3.6.1. In order to add the developed 
prototype firmware to the already existing from Biodevices, S.A. technology, the developed 
firmware was adapted and improved to decrease the power computation need. This 
incorporation resulted in a final device that is able to acquire, save in the SD memory card and 
send via Bluetooth the ECG signal, heart rate, tri-axis accelerometer values, oxygen saturation 
percentage and ambiance temperature and relative humidity. 
 
Figure 3.6.1- Final developed VitalLogger prototype system with the following sensors: 
electrocardiogram (ECG) and heart rate and tri-axis accelerometer from the main board and oxygen 
saturation percentage and ambiance temperature and relative humidity from the developed extension 
board. 
Besides the already implement variables from Biodevices, S.A. technology, VitalLogger is also 
able to transmit, via Bluetooth, the oxygen saturation percentage each second and both of the 
ambiance variables (temperature and relative humidity) with a frequency of 5 seconds. Figure 
3.6.2 shows a Windows SDK application from Biodevices, S.A. with all the variables acquired by 
VitalLogger prototype. When the finger was not inserted in the oxygen saturation sensor, 
VitalLogger sends this information to advice the user, as it is possible to observe in Figure 3.6.3.  
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Figure 3.6.2- Windows SDK application from Biodevices, S.A. during a normal acqu isition from 
VitalLogger prototype. It is possible to see the new variables above the ECG waveform.  
 
 
Figure 3.6.3- Windows SDK application from Biodevices, S.A. during a normal acquisition from 
VitalLogger prototype, but without a finger inserted in the oxygen saturation sensor.  
The developed prototype, due to its size, cannot be introduced in Vital Jacket® portable case 
which is a disadvantage, mainly for a possible future product implementation. To resolve this 
problem it will be presented in the next topic a new prototype idea, with a much more wearable 
solution to transform VitalLogger prototype in a possible product. 
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3.7.  Prototype Improvements 
In the last topic the final prototype was showed and, as it was possible to see, it is big and 
cannot be putted inside Vital Jacket® case. The extension prototype size could be reduced if the 
power management was removed and if oxygen saturation sensor connector (DB9 connector) 
evolves to a different and smaller connector. To solve these problems and try to evolve this 
extension prototype into a possible product, it was made an improvement suggestion for a 
future implementation of the developed extension prototype directly on the Biodevices, S.A. 
board. 
To resolve the power management space needed, the extension prototype board was tested 
with a direct supply off 3.3V and 5V in the AFE4400 RX and TX routes respectively. As shown in 
Appendix B, the test was successfully done, obtaining the same electrical characteristics signals 
as the first developed extension board. After the validation of the results obtained with these 
new power supply (Appendix B), a size reduction was made as also some modifications that are 
going to be discussed in the following lines. 
The main idea of the prototype improvement was to make a module for the main board with 
a won microcontroller to acquire the signal, performing all the signal processing needed and 
calculating the SpO2 percentage value. This improvement will allow acquire values at a higher 
frequency, obtaining a more detailed SpO2 curve, mainly at high heart rates. The SpO2 value and 
the ambiance and relative humidity would be then read by the main microcontroller in the main 
board, requiring a much lower computation effort from it comparing to the developed prototype. 
To make this communication the new microcontroller would work as a master to acquire 
samples from the sensors and then as a slave to send the final values to the main 
microcontroller, alternating its SPI initialization between master and slave. 
The microcontroller chosen was the PIC18F26K20 from Microchip, due to its similarity to the 
one in the main board, decreasing the effort in the firmware adaptation. Another problem 
concerning the implementation of a microcontroller is its programming operation. This problem 
was solved using a specific group of pads in the proposed module hardware, using spring 
connectors (Figure 3.7.1) to import the firmware directly to the module microcontroller. With 
this technology it is possible to change/update this microcontroller firmware without 
interfering with the main board microcontroller, having an independent module. It was also 
included an ADC_RDY digital pin in the module, named D_RDY, allowing the microcontroller 
from the module to inform the main board microcontroller when new data is ready to be read. 
 
Figure 3.7.1- Programming connector used to program the microcontroller in the module. This connector has six 
connections with spring connector and three metal guides to help in the connector positioning in the board.  It is 
developed by Tag-Connect and the other side of the cable is an internet connector (RJ12 connector) that plugs directly 
to ICD-3, which is the programmer used in this work. [97] 
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The components architecture concerning the implementation of this prototype in the main 
board is represented in Figure 3.7.2. In this figure the communication between components is 
only represented when related to the new prototype module. 
 
Figure 3.7.2- New VitalLogger components architecture with the new suggested module implemented 
in the main board. 
The following image (Figure 3.7.3) shows the microcontroller schematic of this VitalLogger 
module version prototype, as also the programming module (TC1) and a pull-up power supply 
protector for the 3.3V.  
 
Figure 3.7.3- Microcontroller schematic (PIC18F26K20_Spo2) designed for this module application. In the left 
bottom of the image is represented the schematic of the programming connector (TC1) and below is the pull-up 
resistor used in the 3.3V supply voltage. [97, 98] 
The AFE4400 schematic (Figure 3.7.4) was also changed to reduce its size and introduce the 
new direct power supply of 3.3V and 5V. The previous DB9 connector was also removed and it 
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evolved to a SpO2 sensor that will be part of the main connector from Vital Jacket® T-shirt. 
Although this idea was not yet implemented, it was already discussed, analyzing its viability for a 
possible future product and the results are positive, being possible to adapt the conventional 
technology to implement this new sensor connection. This new sensor would be smaller than 
the commercial one used in this project, and with a possible adaptability to the human ear. 
 
Figure 3.7.4- Adapted schematic of the AFE4400 module from the developed module prototype to be 
included in this new module unit.  
To acquire ambiance temperature and relative humidity, as it can be seen in figure 3.7.5, it 
was used almost the same schematic as the one implemented in the developed prototype. 
 
Figure 3.7.5- Adapted schematic of HIH6130 module from the developed prototype to be included in 
this new module unit.  
After the module schematic done, the PCB and 3D design were made. The module size was 
defined by Biodevices, S.A. and then all the electronics was designed on it. The module as 
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approximately 2.2 cm per 3cm, which is less than half the size of the developed prototype and 
has already a microcontroller included. All the electronic components were putted in the top 
layer to allow the module to be mounted on the top of the main board without any component 
between both boards. The following images (Figures 3.7.6 and 3.7.7) show the designed PCB, 
also with two layers, and the respective 3D board model with all the needed components. 
  
Figure 3.7.6- Printed circuit board layers of the new module unit (top layer -left image; bottom layer-
right image).  
 
Figure 3.7.7- 3D model of the new developed module unit. The label in the figure indicates the main 
components and the AFE4400 module.  
Regarding the electrical consumption characteristics, this module is very similar to the 
developed prototype, with a theoretical current consumption of 5mA, a bit more due to the 
microcontroller implementation. This will provide almost the same continuous monitoring time 
as the developed prototype, of about 28.5 hours. 
PIC18F26K20 
HIH6130 
Programming 
Connector 
AFE4400 
Module 
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The associated costs (Table IX) is one of the most improved characteristic of this module, 
decreasing more than 10€ independently of the number of produced units. This decrease is due 
to a smaller PCB and a small amount of electronic components used. 
Table IX- This table shows the associated costs of the designed module regarding the electrical 
components and PCB costs per each unit produced according to the number of units produced  In the last 
column of the table a total cost per unit is presented.  
Produced Units 
Electrical Components 
Cost per unit 
PCB Cost per unit 
Prototype Cost 
per unit 
10 20.77 € 6.44 € 27.21 € 
50 18.76 € 1.88 € 20.64 € 
100 17.28 € 1.30 € 18.58 € 
 
In relation to the costs and electrical consumption of the new sensor idea previously referred, 
it is expected to have a lower production cost comparing with the commercial ones, due to its 
structure simplicity and smaller size, but a similar consume if implemented in the finger. 
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  Chapter 4
Conclusions and Future Work 
earable health devices interest is growing and this Master Thesis showed that the 
technology in this area still has much to evolve and increase during the following 
years.  In this work an effort was made to contribute in this emerging area by creating 
a prototype for a possible market expansion of a commercial wearable health device. The 
prototype was successfully developed and implemented, creating the first VitalLogger prototype 
capable to acquire three more variables (physiological oxygen saturation level and ambiance 
temperature and relative humidity) beyond the already acquired by Vital Jacket®. As expected, 
more work must be done to take this prototype closer from a possible commercialization. The 
following lines will refer some aspects that must be improved as also some problems to 
overcome, both to increase this prototype feasibility for medical and personal use. 
The proposed module version of the developed board prototype needs to be produced, 
assembled, tested and validated. It is also necessary to develop the code implementation to 
change the microcontroller SPI module from master to slave and vice versa, as also its 
communication with the microcontroller from the main board. Since a microcontroller will be 
used only for the developed prototype new variables acquisition, a higher sampling rate should 
be implemented, obtaining a better PPG waveform, even at high heart rates. An FFT oxygen 
saturation level calculation could also be implemented and tested to evaluate its performance in 
this system. To test this module it is fundamental to improve the existing VitalJacket® connector 
to be able to incorporate an oxygen saturation sensor. Regarding this sensor itself, it would be of 
great value to create a personalized sensor and, if possible, with a possible implementation for 
the human ear. This solution was already discussed, but is important to retain that, in my 
opinion, an ear oxygen saturation sensor would be better to use in wearable system, not needing 
to have wires along the arm, until the finger, just a short cable from the T-shirt collar to the ear. 
This sensor should be small and easy to attach to the ear. Due to a smaller tissue volume 
W 
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compared to the finger, an ear sensor could reduce the electrical consumption from the LEDs 
sensor, increasing wearable system battery lifetime. 
Regarding the oxygen saturation module, it would be very important to get access to the 
medical certification characteristics document for this type of sensor (ISO 80601-2-61:2011). 
With this document, it would be possible to adapt the properties and acquisition procedure of 
the pulse oximeter module, obtaining a sensor capable to be medically certified and used for 
medical purpose as an oxygen saturation sensor.  
With these improvements it would be possible extend Biodevices, S.A. technology, with an 
already certified pulse oximetry sensor, a higher benefit that would allow a direct use of it in the 
medical environment. After this improvement it would be interesting to study the possibility to 
estimate blood pressure from ECG and PPG signals as mentioned in the researched literature. 
All the small technology advances are important in its evolution and this Master Thesis had 
the aim to contribute in the expansion of a WHD, contributing with one more step in this area. 
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Appendix 
Appendix A – Second Version of 
VitalLogger Extension Board 
 
Figure A. 1- PCB design of VitalLogger extension board second prototype that was not produced. The 
left image shows the top layer and the right image the bottom layer.  
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Figure A. 2- 3D model of the VitalLogger extension board second prototype that was not produced. 
The left image shows the top view of the prototype and the right image the bottom view.  
Appendix B - VitalLogger Modular 
Extension Power Supply Verification 
To verify the possibility to supply the AFE4400 with a direct supply of 3.3V and 5V, the 
components not related to this module were removed from one of the three boards assembled 
(Figure A.3). This evaluation was based on the TXP and TXN comparison between this board 
with a new configuration and the developed prototype extension, concluding that the results are 
very similar (Figure A.4-5). This evaluation is made based on the Texas Instrument AFE4400 
evaluation module datasheet [87]. 
 
Figure A. 3- Prototype extension board adaptation to test the direct power supply of 3.3V and 5V.  
Ground 
3.3V 
5V 
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Figure A. 4- TXP (yellow signal) and TXN (green signal) signals obtained, when the s ensor is 
disconnected, from the developed prototype extension (left image) and from the board with a new 
configuration (right image).  
 
   
Figure A. 5- TXP (yellow signal) and TXN (green signal) signals obtained, when the sens or is 
connected, from the developed prototype extension (left image) and from the board with a new 
configuration (right image).  
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